National Health Act 1953 Determinations under sections 85, 85A and 88 Pharmaceutical benefits (No. PB 68 of 2010) (Cth)
Determination — Pharmaceutical benefits
(PB 68 of 2010)
as amended
made under sections 85, 85A and 88 of the
National Health Act 1953
This compilation was prepared on 1 November 2010
taking into account amendments up to PB 96 of 2010
Prepared by the Office of Legislative Drafting and Publishing,
Attorney‑General’s Department, Canberra
Determinations — pharmaceutical benefits (PB 68 of 2010)
Commencement [see Note 1]
1. This instrument commences on 1 August 2010.
Repeal
2. Instrument number PB 15 of 2010 is repealed.
Definitions
3. In this instrument:
“Act” means the National Health Act 1953;
“authorised midwife” has the meaning given by subsection 84(1) of the Act;
“authorised nurse practitioner” has the meaning given by subsection 84(1) of the Act;
“base-priced drug” means —
(a) in relation to ranitidine (tablet, effervescent, 150 mg (as hydrochloride) or syrup 150 mg (as hydrochloride) per 10 mL, 300 mL): cimetidine or famotidine or nizatidine or ranitidine (tablet 150 mg (as hydrochloride) or tablet 300 mg (as hydrochloride)); or
(b) in relation to lercanidipine or nifedipine (tablet 20 mg (controlled release)): amlodipine, felodipine or nifedipine (tablet 10 mg or tablet 20 mg or tablet 30 mg (controlled release) or tablet 60 mg (controlled release)); or
(c) in relation to eprosartan (tablet 400 mg (as mesylate)): candesartan, eprosartan (tablet 600 mg (as mesylate)), irbesartan, olmesartan, telmisartan or valsartan;
“CFC” means chlorofluorocarbon;
“CFU” means colony forming unit;
“electronic communication” has the meaning given by subsection 5(1) of the Electronic Transactions Act 1999;
“g” means gram;
“GP Management Plan” means a comprehensive written plan for the treatment of a patient, prepared by a medical practitioner, that includes a description of the patient's health care needs, management goals, actions to be taken by the patient and treatment and services the patient is likely to need;
“I.M.” means intramuscular;
“I.U.” means international unit;
“I.V.” means intravenous;
“kg” means kilogram;
“L” means litre;
“m” means metre;
“Medicare Australia CEO” means the Chief Executive Officer of Medicare Australia;
“mg” means milligram;
“mL” means millilitre;
“mm” means millimetre;
“mmol” means millimole;
“palliative care patient”, in relation to a purpose specified in Part 2 of Schedule 2, means a patient with an active, progressive, far-advanced disease, and for whom the prognosis is limited and the focus of care is the quality of life;
“participating dental practitioner” has the meaning given by subsection 84(1) of the Act;
“PBS” means Pharmaceutical Benefits Scheme;
“Regulations” means the National Health (Pharmaceutical Benefits) Regulations 1960 made under the Act;
“Team Care Arrangements” means a document prepared by a medical practitioner, following consultation with collaborating providers, that includes a description of the treatment and service goals for the patient, the treatment and services that all collaborating providers will provide and the actions to be taken by the patient.
Form
4. For the purposes of subsection 85(3) of the Act, where the strength, type of unit, size of unit or other particulars of form are mentioned in Schedule 1 or, if not mentioned in Schedule 1, in Schedule 2 in relation to a listed drug, these particulars are the form or forms of that listed drug.
4A. For the purposes of subsection 85(3) of the Act, a form mentioned in Schedule 4 is a form of a medicinal preparation composed of one or more drugs or medicinal preparations, including a medicinal preparation containing an additive.
Manner of administration
5. For the purposes of subsection 85(5) of the Act, the manner of administration mentioned under the column headed “Manner of administration” in Schedule 1 or, if not mentioned in Schedule 1, in Schedule 2 for a form of a listed drug is the manner of administration for that form of the listed drug.
Brand
5A. For the purposes of subsection 85(6) of the Act, a brand mentioned in Schedule 1 or, if not mentioned in Schedule 1, in Schedule 2 for a listed drug in a pharmaceutical item, in a form and with a manner of administration mentioned for the listed drug, is the brand of that pharmaceutical item.
Participating dental practitioners
5B. For the purposes of subsection 88(1A) of the Act, the pharmaceutical benefits mentioned in Schedule 3 are the pharmaceutical benefits for the supply of which a participating dental practitioner is authorised to write a prescription.
Authorised midwives
5C. For the purposes of subsection 88(1D) of the Act, the pharmaceutical benefits identified in Part 1 of Schedule 1 by “[MW]” in the column headed “Listed Drug”, including where “[NP]” is also mentioned in that column, are the pharmaceutical benefits for the supply of which an authorised midwife is authorised to write a prescription, except where [MW] is also included in the column headed “Form (strength, type, size, etc)”. Where [MW] is also included in the column headed “Form (strength, type, size, etc)”, the pharmaceutical benefits mentioned for that form or forms of the listed drug, are the pharmaceutical benefits for the supply of which an authorised midwife is authorised to write a prescription. The [MW] when included in the column headed “Listed Drug” does not constitute part of the name of the listed drug; nor does [MW], when included with the form of a listed drug, constitute part of the form of the pharmaceutical item or pharmaceutical benefit.
Authorised nurse practitioners
5D. For the purposes of subsection 88(1E) of the Act, the pharmaceutical benefits identified in Schedule 1 or Schedule 2 by “NP” in the column headed “Listed Drug”, including where [MW] is also mentioned in that column, are the pharmaceutical benefits for the supply of which an authorised nurse practitioner is authorised to write a prescription, except where [NP] is also included in the column headed “Form (strength, type, size, etc)” or “Maximum number of repeats”. Where [NP] is also included in the column headed “Form (strength, type, size, etc)” or “Maximum number of repeats” the pharmaceutical benefits mentioned for that form or forms of the listed drug or for that number of repeats for that form of the listed drug, are the pharmaceutical benefits for the supply of which an authorised nurse practitioner is authorised to write a prescription. The identifier [NP], when included in the columns headed “Listed Drug”, “Form” or “Maximum number of repeats”, does not form part of the name of the listed drug; form, or number of repeats for the pharmaceutical item or pharmaceutical benefit.
Prescription
6. For the purposes of subsection 85A(2) of the Act, the quantities and numbers of repeats specified in Part 2 of Schedule 1 or of Schedule 2 for a pharmaceutical item or pharmaceutical benefit are the maximum quantities and number of repeats that a medical practitioner may prescribe or direct on one occasion for the purposes mentioned for the pharmaceutical item or pharmaceutical benefit and no other purposes.
7. For the purposes of subsection 85A(2) of the Act, the quantities and numbers of repeats specified in Part 2 of Schedule 3 for a pharmaceutical benefit or pharmaceutical item are the maximum quantities and number of repeats that a participating dental practitioner may prescribe or direct on one occasion but only for the purposes mentioned for the pharmaceutical item or pharmaceutical benefit and no other purposes.
7A. For the purposes of subsection 85A(2) of the Act, the quantities and numbers of repeats in Part 2 of Schedule 1 or of Schedule 2 for a pharmaceutical item or pharmaceutical benefit where [NP] is included in the column headed “Listed Drug”, except where [NP] is also included in the column headed “Form (strength, type, size, etc)” or “Maximum number of repeats”, are the maximum quantities and number of repeats that an authorised nurse practitioner may prescribe or direct on one occasion for the purposes mentioned in the pharmaceutical item or pharmaceutical benefit and not for other purposes. Where [NP] is also included in the column headed “Form (strength, type, size, etc)”, the quantities and numbers of repeats that apply for prescribing by an authorised nurse practitioner are the maximum quantities and number of repeats specified for that form of the listed drug. Where [NP] is also included in the column headed “Maximum number of repeats” the numbers of repeats that apply for prescribing by an authorised nurse practitioner are the maximum number of repeats specified for the form of the listed drug.
8. For the purposes of subsection 85A(2) of the Act, the manner of administration, if any, mentioned for a pharmaceutical benefit in
(a) Schedule 1 or, if not mentioned in Schedule1, in Schedule 2, is the only manner in which a medical practitioner may, in a prescription, direct the pharmaceutical benefit to be administered; or
(aa) Schedule 1, for a pharmaceutical item or pharmaceutical benefit where [MW] is included in the column headed “Listed Drug”, including where [NP] is also mentioned in that column, or [MW] is also included in the column headed “Form (strength, type, size, etc)”, is the only manner in which an authorised midwife may, in a prescription, direct the pharmaceutical benefit to be administered;
(ab) Schedule 1, or if not mentioned in Schedule 1, in Schedule 2, for a pharmaceutical item or pharmaceutical benefit where [NP] is included in the column headed “Listed Drug”, including where [MW] is also mentioned in that column, or [NP] is also included in the column headed “Form (strength, type, size, etc)” or “Maximum number of repeats”, is the only manner in which an authorised nurse practitioner may, in a prescription, direct the pharmaceutical benefit to be administered;
(b) Schedule 3, is the only manner in which a participating dental practitioner may, in a prescription, direct the pharmaceutical benefit to be administered.
9. For the purposes of subsection 85A(2) of the Act, the maximum quantity or number of units of a pharmaceutical item or pharmaceutical benefit that may, in one prescription, be directed to be supplied on any one occasion is:
(a) where a pharmaceutical item or pharmaceutical benefit is mentioned —
(i) in Part 1 of Schedule 1 — the quantity or number, if any, specified in that Part in the column headed “Maximum quantity” in relation to the pharmaceutical item or pharmaceutical benefit; or
(ii) in Part 2 of Schedule 1 and the pharmaceutical item or pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, specified in that Part in the column headed “Maximum quantity” in relation to the pharmaceutical item or pharmaceutical benefit; or
(iii) in Part 1 of Schedule 2 — the quantity or number, if any, specified in that Part in the column headed “Maximum quantity” in relation to the pharmaceutical item or pharmaceutical benefit; or
(iv) in Part 2 of Schedule 2 and the pharmaceutical item or pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum quantity” in relation to the pharmaceutical item or pharmaceutical benefit; or
(v) in Part 1 of Schedule 3 — the quantity or number, if any, specified in that Part in the column headed “Maximum quantity” in relation to the pharmaceutical item or pharmaceutical benefit; or
(vi) in Part 2 Schedule 3 and the pharmaceutical item or pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum quantity” in relation to the pharmaceutical item or pharmaceutical benefit; or
(b) in any other case — the quantity or number, if any, specified in the column headed “Maximum quantity” in Schedule 4 for the form of the pharmaceutical benefit.
10. For the purposes of subsection 85A(2) of the Act, the maximum number of occasions, if any, on which the supply of a pharmaceutical benefit may, in one prescription, be directed by a medical practitioner to be repeated is:
(a) where the pharmaceutical benefit is mentioned —
(i) in Part 1 of Schedule 1 — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or
(ii) in Part 2 of Schedule 1 and the pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or
(iii) in Part 1 of Schedule 2 — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or
(iv) in Part 2 of Schedule 2 and the pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or
(b) in any other case — the number, if any, specified in the column headed “Maximum number of repeats” in Schedule 4 for the form of the pharmaceutical benefit.
10A. For the purposes of subsection 85A(2) of the Act, the maximum number of occasions, if any, on which the supply of a pharmaceutical benefit mentioned in Part 1 of Schedule 1 where [MW] is included in the column headed “Listed Drug”, including where [NP] is also mentioned in that column, or where [MW] is also in the column headed “Form (strength, type, size, etc)”, may, in one prescription, be directed by an authorised midwife to be repeated is the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit.
10B. For the purposes of subsection 85A(2) of the Act, the maximum number of occasions, if any, on which the supply of a pharmaceutical benefit in Schedule 1 or Schedule 2 where [NP] is included in the column headed “Listed Drug”, including where [MW] is mentioned in that column, or where [NP] is also in the column headed “Form (strength, type, size, etc)” or “Maximum number of repeats”, may, in one prescription, be directed by an authorised nurse practitioner to be repeated is, where the pharmaceutical benefit is mentioned:
(a) in Part 1 of Schedule 1 — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or
(b) in Part 2 of Schedule 1 and the pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or
(c) in Part 1 of Schedule 2 — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or
(d) in Part 2 of Schedule 2 and the pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit.
11. Subject to paragraph 14, the following purposes are specified in relation to each pharmaceutical benefit mentioned in Part 2 of Schedule 1 or 2:
(a) where a class of persons is specified in the column headed “Purposes” — that the pharmaceutical benefit is to be supplied for the treatment of a person included in that class of persons;
(b) where a disease or condition is specified in the column headed “Purposes”
(i) if subsubparagraph (ii) does not apply — that the pharmaceutical benefit is to be supplied for the treatment of that disease or condition in relation to any person; or
(ii) if the disease or condition is specified in relation to a specified class of persons — that the pharmaceutical benefit is to be supplied for the treatment of that disease or condition in a person included in that class of persons;
(c) where a purpose is specified in the column headed “Purposes” — that the pharmaceutical benefit is to be supplied for that purpose;
(d) where it is specified in the column headed “Purposes” that compliance with authority procedures set out in subparagraph 11(d) is required — that a medical practitioner or an authorised nurse practitioner has submitted to the Medicare Australia CEO a prescription for the supply of the pharmaceutical benefit:
(i) by delivering or posting to the Medicare Australia CEO the prescription prepared and signed by the medical practitioner or authorised nurse practitioner:
(A) in a form approved by the Secretary and completed by the medical practitioner or authorised nurse practitioner in ink in his or her own handwriting; or
(B) in a form, prepared by means of a computer, that is in accordance with the form approved by the Secretary under subsubsubparagraph (A); or
(C) in a form, prepared by means of a computer, approved in writing for the purpose by the Secretary and in the format approved in writing by the Secretary; or
(D) by a method approved in writing by the Secretary; or
(ii) by submitting the prescription by giving the Medicare Australia CEO by telephone, details of the prescription which has been prepared and signed by the medical practitioner or authorised nurse practitioner in accordance with subsubparagraph (i); or
(iii) where the medical practitioner or authorised nurse practitioner has attempted to obtain an authorisation by submitting details of the prescription to the Medicare Australia CEO in accordance with subsubparagraph (ii) but has been unable to do so because of a failure or other form of unavailability in the telephone system established by the Medicare Australia CEO for the provision of such authorisations, by submitting the prescription in accordance with the instructions stipulated in an emergency telephone message provided to the medical practitioner or authorised nurse practitioner by the Medicare Australia CEO; or
(iv) by submitting the prescription by giving the Medicare Australia CEO, by means of an electronic communication of a kind approved in writing by the Medicare Australia CEO, details of the prescription which has been prepared and signed by the medical practitioner or authorised nurse practitioner in accordance with subsubparagraph (i).
11A. For the purposes of subparagraph 11(d)(i), a prescription that has been prepared and signed by the medical practitioner or authorised nurse practitioner in accordance with that subparagraph is taken to have been submitted by him or her if it is submitted by one of his or her employees.
12. Subject to paragraph 12B, the authorisation of a prescription submitted under subparagraph 11(d) may be made:
(a) if the prescription was submitted in accordance with subsubparagraph 11(d)(i) — by the Medicare Australia CEO signing his or her authorisation of the prescription on it and:
(i) if the Medicare Australia CEO requires the medical practitioner or authorised nurse practitioner to alter the prescription — by returning it to the medical practitioner or authorised nurse practitioner for alteration before the medical practitioner or authorised nurse practitioner gives it to the person in respect of whom it was prepared; or
(ii) in any other case:
(A) by returning it to the medical practitioner or authorised nurse practitioner; or
(B) by sending it to the person in respect of whom it was prepared; or
(b) if the prescription was submitted in accordance with subsubparagraph 11(d)(ii) — orally, at the time the Medicare Australia CEO is given details of the prescription; or
(c) if the prescription was submitted in accordance with subsubparagraph 11(d)(iv) — by the Medicare Australia CEO sending his or her authorisation, by electronic communication, to the medical practitioner or authorised nurse practitioner.
12A. If the Medicare Australia CEO authorises a prescription in accordance with subparagraph 12(b) or (c):
(a) the Medicare Australia CEO must tell the medical practitioner, orally or by electronic communication, or an authorised nurse practitioner, orally, the number that has been allotted to the authorised prescription; and
(b) the medical practitioner or authorised nurse practitioner must:
(i) mark that number on the prescription; and
(ii) retain a copy of the prescription for 1 year from the date on which the prescription was authorised.
12B. Notwithstanding paragraph 12, if the prescription was submitted in accordance with subsubparagraph 11(d)(iii), authorisation shall be deemed to have been granted upon completion by the medical practitioner or authorised nurse practitioner of the prescription in accordance with the instructions stipulated in the emergency telephone message provided to the medical practitioner or authorised nurse practitioner by the Medicare Australia CEO.
12BA. If a medical practitioner or an authorised nurse practitioner has written on a prescription, that has been prepared and signed in accordance with subsubparagraph 11(d)(i), the streamlined authority code mentioned in Part 2 of Schedule 1 for a pharmaceutical benefit and purpose:
(a) subparagraph 11(d) is taken to have been complied with; and
(b) the Medicare Australia CEO is taken to have authorised the prescription.
12BB. Paragraph 12BA applies to a prescription only if there is a streamlined authority code for the pharmaceutical benefit and purpose in Part 2 of Schedule 1.
12C. Where a prescription is authorised, or deemed to be authorised, in accordance with paragraph 12, and an authorisation is also granted in accordance with subregulation 13(5) of the Regulations increasing the maximum quantity or number of units of the pharmaceutical benefit that may, in the prescription, be directed to be supplied on any one occasion, or the maximum number of occasions on which the supply of the pharmaceutical benefit may, in the prescription, be directed to be repeated, the authorisation in accordance with paragraph 12 is taken to be for the prescription of the increased quantity, number, or occasions, as the case may be.
13. The following purposes are specified in relation to a pharmaceutical benefit mentioned in Part 2 of Schedule 3:
(a) where a class of persons is specified in the column headed “Purposes” — that the pharmaceutical benefit is to be supplied for the treatment of a person included in that class of persons;
(b) where a disease or condition is specified in the column headed “Purposes” —
(i) if subsubparagraph (ii) does not apply — that the pharmaceutical benefit is to be supplied for the treatment of that disease or condition in relation to any person; or
(ii) if the disease or condition is specified in relation to a specified class of persons — that the pharmaceutical benefit is to be supplied for the treatment of that disease or condition in a person included in that class of persons;
(c) where a purpose is specified in the column headed “Purposes” — that the pharmaceutical benefit is to be supplied for that purpose.
14. Where the purposes “For use in accordance with paragraph 14” are specified in the column headed “Purposes” in Part 2 of Schedule 1, the purposes specified for the purpose of subparagraph 11(c) are:
(a) that the pharmaceutical benefit is to be supplied for the treatment, in conjunction with dietary therapy, of a patient identified as being in one of the following very high risk categories:
(i) coronary heart disease which has become symptomatic;
(ii) cerebrovascular disease which has become symptomatic;
(iii) peripheral vascular disease which has become symptomatic;
(iv) diabetes mellitus with microalbuminuria (defined as urinary albumin excretion rate of greater than 20 micrograms per minute, or urinary albumin to creatinine ratio of greater than 2.5 for males or greater than 3.5 for females);
(v) diabetes mellitus in Aboriginal or Torres Strait Islander patients;
(vi) diabetes mellitus in patients aged 60 years or more;
(vii) family history of coronary heart disease which has become symptomatic before the age of 55 years in two or more first degree relatives;
(viii) family history of coronary heart disease which has become symptomatic before the age of 45 years in one or more first degree relatives; or
(b) if subparagraph 14(a) does not apply — that the pharmaceutical benefit is to be supplied for the treatment, in conjunction with dietary therapy, of a patient who, after at least 6 weeks of dietary therapy, qualifies for the supply of the benefit in accordance with the following table:
Category of patient Fasting lipid level Patients with diabetes mellitus not otherwise
includedtotal cholesterol greater than 5.5 mmol per L Aboriginal or Torres Strait Islander patients;
Patients with hypertensiontotal cholesterol greater than 6.5 mmol per L;
or
total cholesterol greater than 5.5 mmol per L and high density lipoprotein cholesterol less than 1 mmol per L
Patients with high density lipoprotein cholesterol less than 1 mmol per L total cholesterol greater than 6.5 mmol per L Patients with familial hypercholesterolaemia identified by:
(1) DNA mutation; or
(2) tendon xanthomas in the patient or their first or second degree relative
Patients with:
(1) family history of coronary heart disease which has become symptomatic before the age of 60 years in one or more first degree relatives; or
(2) family history of coronary heart disease which has become symptomatic before the age of 50 years in one or more second degree relatives
If aged 18 years or less at treatment initiation:
low density lipoprotein cholesterol greater than 4 mmol per L
If aged more than 18 years at treatment initiation:low density lipoprotein cholesterol greater than 5 mmol per L;
or
total cholesterol greater than 6.5 mmol per L;
or
total cholesterol greater than 5.5 mmol per L and high density lipoprotein cholesterol less than 1 mmol per L
Patients not eligible under the above:
(1) men over 34 but less than 76 years of age; or
(2) post-menopausal women less than 76 years of age
total cholesterol greater than 7.5 mmol per L;
or
triglyceride greater than 4 mmol per L
Patients not otherwise included total cholesterol greater than 9 mmol per L;
or
triglyceride greater than 8 mmol per L
| SCHEDULE 1 - PART 1 | |||||
| Listed Drug | Form (strength, type, size, etc.) | Manner of adminis- tration | Maximum quantity | Maximum number of repeats | Brand |
| Abciximab | I.V. injection 10 mg in 5 mL vial | Injection | 3 | .. | ReoPro |
| Acamprosate [NP] | Tablet (enteric coated) containing acamprosate calcium 333 mg | Oral | 180 | 1 | Campral |
| Acarbose [NP] | Tablet 50 mg | Oral | 90 | 5 | Glucobay 50 |
| Tablet 100 mg | Oral | 90 | 5 | Glucobay 100 | |
| Acetazolamide [NP] | Tablet 250 mg | Oral | 100 | 3 | Diamox |
| Aciclovir [NP] | Tablet 200 mg | Oral | 50 | .. | Acihexal |
| Acyclo-V 200 | |||||
| GenRx Aciclovir | |||||
| Lovir | |||||
| Zovirax 200 mg | |||||
| Tablet 800 mg | Oral | 35 | .. | Aciclovir 800 | |
| Acihexal | |||||
| Acyclo-V 800 | |||||
| GenRx Aciclovir | |||||
| Zovirax 800 mg | |||||
| Eye ointment 30 mg per g, 4.5 g | Application to the eye | 1 | .. | Zovirax | |
| Acitretin | Capsule 10 mg | Oral | 100 | 2 | Neotigason |
| Capsule 25 mg | Oral | 100 | 2 | Neotigason | |
| Adalimumab | Injection 40 mg in 0.8 mL pre-filled syringe, 6 | Injection | 1 | .. | Humira |
| Injection 40 mg in 0.8 mL pre-filled pen, 6 | Injection | 1 | .. | Humira | |
| Injection 40 mg in 0.8 mL pre-filled syringe | Injection | 2 | 2 | Humira | |
| Injection 40 mg in 0.8 mL pre-filled pen | Injection | 2 | 2 | Humira | |
| Adrenaline [NP] | Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000) | Injection | 5 | 1 | AstraZeneca Pty Ltd |
| I.M. injection 150 micrograms in 0.3 mL single dose syringe auto-injector (EpiPen Jr.) | Injection | 1 | .. | EpiPen Jr. | |
| I.M. injection 150 micrograms in 0.3 mL single dose syringe auto-injector (Anapen Junior) | Injection | 1 | .. | Anapen Junior | |
| I.M. injection 300 micrograms in 0.3 mL single dose syringe auto-injector (EpiPen) | Injection | 1 | .. | EpiPen | |
| I.M. injection 300 micrograms in 0.3 mL single dose syringe auto-injector (Anapen) | Injection | 1 | .. | Anapen | |
| Albendazole [NP] | Tablet 200 mg [NP] | Oral | 6 | .. | Zentel |
| Tablet 400 mg | Oral | 60 | 2 | Eskazole | |
| Alendronic Acid [NP] | Tablet 70 mg (as alendronate sodium) | Oral | 4 | 5 | Adronat |
| Alendrobell 70mg | |||||
| Alendronate-GA | |||||
| Alendronate Sandoz | |||||
| Alendro Once Weekly | |||||
| APO-Alendronate | |||||
| Chem mart Alendronate 70mg | |||||
| Fosamax Once Weekly | |||||
| Ossmax 70mg | |||||
| Terry White Chemists Alendronate 70mg | |||||
| Tablet 40 mg (as alendronate sodium) | Oral | 30 | 5 | Fosamax 40 mg | |
| Alendronic acid with colecalciferol [NP] | Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol | Oral | 4 | 5 | Fosamax Plus |
| Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol | Oral | 4 | 5 | Dronalen Plus | |
| Fosamax Plus 70 mg/140 mcg | |||||
| Alendronic acid with colecalciferol and calcium [NP] | Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate) | Oral | 1 | 5 | Fosamax Plus D-Cal |
| Alginic acid with calcium carbonate and sodium bicarbonate [NP] | Oral liquid containing alginic acid as sodium alginate 1 g, calcium carbonate 320 mg and sodium bicarbonate 534 mg in 20 mL, 500 mL | Oral | 2 | 5 | Gaviscon P |
| Allopurinol [NP] | Tablet 100 mg | Oral | 200 | 2 | Allopurinol Sandoz |
| Allosig | |||||
| Chem mart Allopurinol | |||||
| GenRx Allopurinol | |||||
| Progout 100 | |||||
| Terry White Chemists Allopurinol | |||||
| Zyloprim | |||||
| Tablet 300 mg | Oral | 60 | 2 | Allopurinol Sandoz | |
| Allosig | |||||
| Chem mart Allopurinol | |||||
| GenRx Allopurinol | |||||
| Progout 300 | |||||
| Terry White Chemists Allopurinol | |||||
| Zyloprim | |||||
| Alprazolam [NP] | Tablet 250 micrograms | Oral | 50 | .. | Alprax 0.25 |
| Alprazolam Sandoz | |||||
| Kalma 0.25 | |||||
| Xanax | |||||
| Tablet 500 micrograms | Oral | 50 | .. | Alprax 0.5 | |
| Alprazolam Sandoz | |||||
| Kalma 0.5 | |||||
| Xanax | |||||
| Tablet 1 mg | Oral | 50 | 2 | Alprax 1 | |
| Alprazolam-GA | |||||
| Alprazolam Sandoz | |||||
| Chem mart Alprazolam | |||||
| GenRx Alprazolam | |||||
| Kalma 1 | |||||
| Terry White Chemists Alprazolam | |||||
| Xanax | |||||
| Tablet 2 mg | Oral | 50 | 2 | Alprax 2 | |
| Alprazolam-GA | |||||
| Alprazolam Sandoz | |||||
| Chem mart Alprazolam | |||||
| GenRx Alprazolam | |||||
| Kalma 2 | |||||
| Terry White Chemists Alprazolam | |||||
| Xanax Tri-Score | |||||
| Aluminium Hydroxide with Magnesium Hydroxide [NP] | Oral suspension 200 mg-200 mg per 5 mL, 500 mL | Oral | 2 | 5 | Mylanta P |
| Aluminium Hydroxide with Magnesium Trisilicate and Magnesium Hydroxide [NP] | Oral suspension 250 mg-120 mg-120 mg per 5 mL, 500 mL | Oral | 2 | 5 | Gastrogel |
| Amantadine [NP] | Capsule containing amantadine hydrochloride 100 mg | Oral | 100 | 5 | Symmetrel 100 |
| Amiloride [NP] | Tablet containing amiloride hydrochloride 5 mg | Oral | 100 | 1 | Kaluril |
| Amino acid formula with fat, carbohydrate, vitamins, minerals, and trace elements, without methionine and supplemented with docosahexanoic acid [NP] | Oral liquid 125 mL, 36 (HCU Anamix junior LQ) | Oral | 4 | 5 | HCU Anamix junior LQ |
| Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine, and supplemented with docosahexanoic acid [NP] | Oral liquid 125 mL, 36 (TYR Anamix junior LQ) | Oral | 4 | 5 | TYR Anamix junior LQ |
| Amino acid formula without phenylalanine [NP] | Capsules 500 mg, 200 (Phlexy-10) | Oral | 16 | 5 | Phlexy-10 |
| Tablets 1 g, 75 (Phlexy-10) | Oral | 24 | 5 | Phlexy-10 | |
| Sachets containing oral powder 20 g, 30 (Phlexy-10 Drink Mix) | Oral | 7 | 5 | Phlexy-10 Drink Mix | |
| Amino acid formula with vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine [NP] | Oral powder 400 g (PKU Anamix infant) | Oral | 8 | 5 | PKU Anamix infant |
| Amino acid formula with vitamins and minerals without lysine and low in tryptophan [NP] | Sachets containing oral powder 20 g, 30 (GA gel) | Oral | 4 | 5 | GA gel |
| Oral powder 400 g (GA1 Anamix infant) | Oral | 8 | 5 | GA1 Anamix infant | |
| Oral powder 500 g (XLYS, LOW TRY Maxamaid) | Oral | 8 | 5 | XLYS, LOW TRY Maxamaid | |
| Amino acid formula with vitamins and minerals without methionine [NP] | Oral powder 400 g (HCU Anamix infant) | Oral | 8 | 5 | HCU Anamix infant |
| Sachets containing oral powder 20 g, 30 (HCU gel) | Oral | 4 | 5 | HCU gel | |
| Sachets containing oral powder 25 g, 30 (HCU express) | Oral | 4 | 5 | HCU express | |
| Oral powder 500 g (XMET Maxamaid) | Oral | 8 | 5 | XMET Maxamaid | |
| Oral powder 500 g (XMET Maxamum) | Oral | 8 | 5 | XMET Maxamum | |
| Oral liquid 130 mL, 30 (HCU Cooler) | Oral | 4 | 5 | HCU Cooler | |
| Amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine [NP] | Sachets containing oral powder 25 g, 30 (MMA/PA express) | Oral | 4 | 5 | MMA/PA express |
| Sachets containing oral powder 20 g, 30 (MMA/PA gel) | Oral | 4 | 5 | MMA/PA gel | |
| Oral powder 400 g (MMA/PA Anamix infant) | Oral | 8 | 5 | MMA/PA Anamix infant | |
| Oral powder 500 g (XMTVI Maxamaid) | Oral | 8 | 5 | XMTVI Maxamaid | |
| Oral powder 500 g (XMTVI Maxamum) | Oral | 8 | 5 | XMTVI Maxamum | |
| Amino acid formula with vitamins and minerals without phenylalanine [NP] | Sachets containing oral powder 18.2 g, 60 (add-ins) | Oral | 3 | 5 | add-ins |
| Sachets containing oral powder 20 g, 30 (PKU-gel) | Oral | 4 | 5 | PKU-gel | |
| Sachets containing oral powder 25 g, 30 (PKU-Express) | Oral | 4 | 5 | PKU-Express | |
| Sachets containing oral powder 27.8 g, 30 (Lophlex) | Oral | 3 | 5 | Lophlex | |
| Sachets containing oral powder 29 g, 30 (PKU Anamix Junior) | Oral | 4 | 5 | PKU Anamix Junior | |
| Sachets containing oral powder 50 g, 30 (XP Maxamum) | Oral | 3 | 5 | XP Maxamum | |
| Oral powder 400 g (Phenex-2) | Oral | 8 | 5 | Phenex-2 | |
| Oral powder 500 g (XP Maxamaid) | Oral | 8 | 5 | XP Maxamaid | |
| Oral powder 500 g (XP Maxamum) | Oral | 8 | 5 | XP Maxamum | |
| Oral liquid 250 mL (Easiphen) | Oral | 90 | 5 | Easiphen | |
| Oral liquid 62.5 mL, 60 (PKU Lophlex LQ 10) | Oral | 2 | 5 | PKU Lophlex LQ 10 | |
| Oral liquid 87 mL, 30 (PKU Cooler 10) | Oral | 4 | 5 | PKU Cooler 10 | |
| Oral liquid 125 mL, 30 (PKU Lophlex LQ 20) | Oral | 3 | 5 | PKU Lophlex LQ 20 | |
| Oral liquid 125 mL, 36 (PKU Anamix Junior LQ) | Oral | 4 | 5 | PKU Anamix Junior LQ | |
| Oral liquid 130 mL, 30 (PKU Cooler 15) | Oral | 4 | 5 | PKU Cooler 15 | |
| Oral liquid 174 mL, 30 (PKU Cooler 20) | Oral | 4 | 5 | PKU Cooler 20 | |
| Amino acid formula with vitamins and minerals without phenylalanine and tyrosine [NP] | Sachets containing oral powder 20 g, 30 (TYR gel) | Oral | 4 | 5 | TYR gel |
| Sachets containing oral powder 25 g, 30 (TYR Express) | Oral | 4 | 5 | TYR Express | |
| Sachets containing oral powder 29 g, 30 (TYR Anamix Junior) | Oral | 4 | 5 | TYR Anamix Junior | |
| Oral powder 400 g (TYR Anamix infant) | Oral | 8 | 5 | TYR Anamix infant | |
| Oral powder 500 g (XPhen, Tyr Maxamaid) | Oral | 8 | 5 | XPhen, Tyr Maxamaid | |
| Oral powder 500 g (XPhen, Tyr Maxamum) | Oral | 8 | 5 | XPhen, Tyr Maxamum | |
| Oral liquid 130 mL, 30 (TYR Cooler) | Oral | 4 | 5 | TYR Cooler | |
| Amino acid formula with vitamins and minerals without valine, leucine and isoleucine [NP] | Sachets containing oral powder 20 g, 30 (MSUD-gel) | Oral | 4 | 5 | MSUD-gel |
| Sachets containing oral powder 25 g, 30 (MSUD Express) | Oral | 4 | 5 | MSUD Express | |
| Sachets containing oral powder 29 g, 30 (MSUD Anamix Junior) | Oral | 4 | 5 | MSUD Anamix Junior | |
| Oral powder 400 g (MSUD Anamix infant) | Oral | 8 | 5 | MSUD Anamix infant | |
| Oral powder 500 g (MSUD AID III) | Oral | 4 | 5 | MSUD AID III | |
| Oral powder 500 g (MSUD Maxamaid) | Oral | 8 | 5 | MSUD Maxamaid | |
| Oral powder 500 g (MSUD Maxamum) | Oral | 8 | 5 | MSUD Maxamum | |
| Oral liquid 130 mL, 30 (MSUD Cooler) | Oral | 4 | 5 | MSUD Cooler | |
| Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexanoic acid [NP] | Oral liquid 125 mL, 36 (MSUD Anamix Junior LQ) | Oral | 4 | 5 | MSUD Anamix Junior LQ |
| Amino acids — synthetic, formula [NP] | Oral powder 400 g (EleCare) | Oral | 8 | 5 | EleCare |
| Oral powder 400 g (Neocate) | Oral | 8 | 5 | Neocate | |
| Oral powder 400 g (Neocate Advance) | Oral | 8 | 5 | Neocate Advance | |
| Oral powder 400 g (Neocate Advance Tropical Flavour) | Oral | 8 | 5 | Neocate Advance Tropical Flavour | |
| Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids [NP] | Oral powder 400 g (Neocate LCP) | Oral | 8 | 5 | Neocate LCP |
| Oral powder 400 g (EleCare LCP) | Oral | 8 | 5 | EleCare LCP | |
| Amiodarone [NP] | Tablet containing amiodarone hydrochloride 100 mg | Oral | 30 | 5 | Aratac 100 |
| Cardinorm | |||||
| Cordarone X 100 | |||||
| Rithmik 100 | |||||
| Tablet containing amiodarone hydrochloride 200 mg | Oral | 30 | 5 | Aratac 200 | |
| Cardinorm | |||||
| Chem mart Amiodarone | |||||
| Cordarone X 200 | |||||
| GenRx Amiodarone | |||||
| Rithmik 200 | |||||
| Terry White Chemists Amiodarone | |||||
| Amisulpride [NP] | Tablet 100 mg | Oral | 30 | 5 | Amisulpride 100 Winthrop |
| Amisulpride Sandoz | |||||
| Solian 100 | |||||
| Sulprix | |||||
| Tablet 200 mg | Oral | 60 | 5 | Amisulpride 200 Winthrop | |
| Amisulpride Sandoz | |||||
| Solian 200 | |||||
| Sulprix | |||||
| Tablet 400 mg | Oral | 60 | 5 | Amipride 400 | |
| Amisulpride 400 Winthrop | |||||
| Amisulpride Sandoz | |||||
| Solian 400 | |||||
| Sulprix | |||||
| Oral solution 100 mg per mL, 60 mL | Oral | 2 | 5 | Solian Solution | |
| Amitriptyline [NP] | Tablet containing amitriptyline hydrochloride 10 mg | Oral | 50 | 2 | Endep 10 |
| Tablet containing amitriptyline hydrochloride 25 mg | Oral | 50 | 2 | Endep 25 | |
| Tablet containing amitriptyline hydrochloride 50 mg | Oral | 50 | 2 | Endep 50 | |
| Amlodipine [NP] | Tablet 5 mg (as besylate) | Oral | 30 | 5 | Amlodipine-DRLA |
| Amlodipine-GA | |||||
| Amlodipine generichealth | |||||
| Amlodipine Sandoz | |||||
| APO-Amlodipine | |||||
| Chem mart Amlodipine | |||||
| Nordip | |||||
| Norvapine | |||||
| Norvasc | |||||
| Ozlodip | |||||
| Perivasc | |||||
| Pharmacor Amlodipine 5 | |||||
| Terry White Chemists Amlodipine | |||||
| Tablet 5 mg (as maleate) | Oral | 30 | 5 | Amlo 5 | |
| Tablet 10 mg (as besylate) | Oral | 30 | 5 | Amlodipine-DRLA | |
| Amlodipine-GA | |||||
| Amlodipine generichealth | |||||
| Amlodipine Sandoz | |||||
| APO-Amlodipine | |||||
| Chem mart Amlodipine | |||||
| Nordip | |||||
| Norvapine | |||||
| Norvasc | |||||
| Ozlodip | |||||
| Perivasc | |||||
| Pharmacor Amlodipine 10 | |||||
| Terry White Chemists Amlodipine | |||||
| Tablet 10 mg (as maleate) | Oral | 30 | 5 | Amlo 10 | |
| Amlodipine with Atorvastatin [NP] | Tablet 5 mg amlodipine (as besylate) with 10 mg atorvastatin (as calcium) | Oral | 30 | 5 | Caduet 5/10 |
| Tablet 5 mg amlodipine (as besylate) with 20 mg atorvastatin (as calcium) | Oral | 30 | 5 | Caduet 5/20 | |
| Tablet 5 mg amlodipine (as besylate) with 40 mg atorvastatin (as calcium) | Oral | 30 | 5 | Caduet 5/40 | |
| Tablet 5 mg amlodipine (as besylate) with 80 mg atorvastatin (as calcium) | Oral | 30 | 5 | Caduet 5/80 | |
| Tablet 10 mg amlodipine (as besylate) with 10 mg atorvastatin (as calcium) | Oral | 30 | 5 | Caduet 10/10 | |
| Tablet 10 mg amlodipine (as besylate) with 20 mg atorvastatin (as calcium) | Oral | 30 | 5 | Caduet 10/20 | |
| Tablet 10 mg amlodipine (as besylate) with 40 mg atorvastatin (as calcium) | Oral | 30 | 5 | Caduet 10/40 | |
| Tablet 10 mg amlodipine (as besylate) with 80 mg atorvastatin (as calcium) | Oral | 30 | 5 | Caduet 10/80 | |
| Amlodipine with valsartan [NP] | Tablet 5 mg (as besylate)-80 mg | Oral | 28 | 5 | Exforge 5/80 |
| Tablet 5 mg (as besylate)-160 mg | Oral | 28 | 5 | Exforge 5/160 | |
| Tablet 10 mg (as besylate)-160 mg | Oral | 28 | 5 | Exforge 10/160 | |
| Amlodipine with valsartan and hydrochlorothiazide | Tablet 5 mg (as besylate)-160 mg-12.5 mg | Oral | 28 | 5 | Exforge HCT 5/160/12.5 |
| Tablet 5 mg (as besylate)-160 mg-25 mg | Oral | 28 | 5 | Exforge HCT 5/160/25 | |
| Tablet 10 mg (as besylate)-160 mg-12.5 mg | Oral | 28 | 5 | Exforge HCT 10/160/12.5 | |
| Tablet 10 mg (as besylate)-160 mg-25 mg | Oral | 28 | 5 | Exforge HCT 10/160/25 | |
| Tablet 10 mg (as besylate)-320 mg-25 mg | Oral | 28 | 5 | Exforge HCT 10/320/25 | |
| Amoxycillin [NP] [MW] | Tablet 1 g (as trihydrate) | Oral | 14 | 1 | Amoxycillin Sandoz |
| Maxamox | |||||
| Capsule 250 mg (as trihydrate) [MW] | Oral | 20 | 1 | Alphamox 250 | |
| Amoxil | |||||
| Amoxycillin-GA | |||||
| Amoxycillin Ranbaxy | |||||
| Amoxycillin Sandoz | |||||
| APO-Amoxycillin | |||||
| Chem mart Amoxycillin | |||||
| Cilamox | |||||
| GenRx Amoxycillin | |||||
| Terry White Chemists Amoxycillin | |||||
| Capsule 500 mg (as trihydrate) [MW] | Oral | 20 | 1 | Alphamox 500 | |
| Amoxil | |||||
| Amoxycillin-GA | |||||
| Amoxycillin Ranbaxy | |||||
| Amoxycillin Sandoz | |||||
| APO-Amoxycillin | |||||
| Chem mart Amoxycillin | |||||
| Cilamox | |||||
| GenRx Amoxycillin | |||||
| Terry White Chemists Amoxycillin | |||||
| Sachet containing oral powder 3 g (as trihydrate) | Oral | 1 | .. | Amoxil | |
| Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL | Oral | 1 | 1 | Amoxil | |
| Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL | Oral | 1 | 1 | Alphamox 125 Amoxil Amoxycillin Sandoz Bgramin Chem mart Amoxycillin GenRx Amoxycillin Ranmoxy Terry White Chemists Amoxycillin | |
| Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL | Oral | 1 | 1 | Alphamox 250 | |
| Amoxil Forte | |||||
| Amoxycillin Sandoz | |||||
| Bgramin | |||||
| Chem mart Amoxycillin | |||||
| Cilamox | |||||
| GenRx Amoxycillin | |||||
| Ranmoxy | |||||
| Terry White Chemists Amoxycillin | |||||
| Powder for oral suspension 500 mg (as trihydrate) per 5 mL, 100 mL | Oral | 1 | 1 | Maxamox | |
| Amoxycillin with Clavulanic Acid [NP] [MW] | Tablet containing 500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) [MW] | Oral | 10 | 1 | Amoxycillin/Clavulanic Acid 500/125 generichealth |
| APO-Amoxycillin/ Clavulanic Acid 500/125 | |||||
| Augmentin Duo | |||||
| Clamoxyl Duo | |||||
| Curam Duo 500/125 | |||||
| GA-Amclav 500/125 | |||||
| Moxiclav Duo 500/125 | |||||
| Tablet containing 875 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) | Oral | 10 | 1 | Amoxycillin/Clavulanic Acid 875/125 generichealth | |
| Augmentin Duo forte | |||||
| Chem mart Amoxycillin and Clavulanic Acid | |||||
| Clamoxyl Duo forte | |||||
| Clavycillin 875/125 | |||||
| Curam Duo Forte 875/125 | |||||
| GA-Amclav Forte 875/125 | |||||
| GenRx Amoxycillin and Clavulanic Acid | |||||
| Moxiclav Duo Forte 875/125 | |||||
| Terry White Chemists Amoxycillin and Clavulanic Acid | |||||
| Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL | Oral | 1 | 1 | Augmentin | |
| Clamoxyl | |||||
| Curam | |||||
| Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL | Oral | 1 | 1 | Augmentin Duo 400 | |
| Clamoxyl Duo 400 | |||||
| Curam Duo | |||||
| Amphotericin [NP] | Lozenge 10 mg | Oral | 20 | 1 | Fungilin |
| Ampicillin [NP] | Powder for injection 500 mg (as sodium) | Injection | 5 | 1 | Austrapen |
| Ibimicyn | |||||
| Powder for injection 1 g (as sodium) | Injection | 5 | 1 | Aspen Ampicyn | |
| Austrapen | |||||
| Ibimicyn | |||||
| Amylopectin, modified long chain [NP] | Sachets containing oral powder 60 g, 30 (Glycosade) | Oral | 4 | 5 | Glycosade |
| Anakinra | Injection 100 mg in 0.67 mL single use pre-filled syringe | Injection | 28 | 3 | Kineret |
| Anastrozole [NP] | Tablet 1 mg | Oral | 30 | 5 | Arimidex |
| Apraclonidine | Eye drops 5 mg (as hydrochloride) per mL, 10 mL | Application to the eye | 1 | 2 | Iopidine 0.5% |
| Aprepitant [NP] | Pack containing 1 capsule 125 mg and 2 capsules 80 mg | Oral | 1 | .. | Emend |
| Arginine with carbohydrate [NP] | Sachets of oral powder 4 g containing 500 mg arginine, 30 (Arginine Amino Acid Supplement) | Oral | 4 | 5 | Arginine Amino Acid Supplement |
| Aripiprazole [NP] | Tablet 10 mg | Oral | 30 | 5 | Abilify |
| Tablet 15 mg | Oral | 30 | 5 | Abilify | |
| Tablet 20 mg | Oral | 30 | 5 | Abilify | |
| Tablet 30 mg | Oral | 30 | 5 | Abilify | |
| Arsenic | Injection concentrate containing arsenic trioxide 10 mg in 10 mL | Injection | 60 | 2 | Phenasen |
| Artemether with lumefantrine | Tablet 20 mg-120 mg | Oral | 24 | .. | Riamet |
| Tablet (dispersible) 20 mg-120 mg | Oral | 18 | .. | Riamet 20mg/120mg Dispersible | |
| Aspirin [NP] | Tablet 100 mg | Oral | 112 | 1 | Astrix |
| DBL Aspirin 100 mg | |||||
| Tablet, dispersible, 300 mg | Oral | 96 | 1 | Solprin | |
| Atenolol [NP] | Tablet 50 mg | Oral | 30 | 5 | APO-Atenolol |
| Atenolol-GA | |||||
| Atenolol Sandoz | |||||
| Chem mart Atenolol | |||||
| Noten | |||||
| Tenormin | |||||
| Tensig | |||||
| Terry White Chemists Atenolol | |||||
| Atomoxetine | Capsule 10 mg (as hydrochloride) | Oral | 56 | 5 | Strattera |
| Capsule 18 mg (as hydrochloride) | Oral | 56 | 5 | Strattera | |
| Capsule 25 mg (as hydrochloride) | Oral | 56 | 5 | Strattera | |
| Capsule 40 mg (as hydrochloride) | Oral | 56 | 5 | Strattera | |
| Capsule 60 mg (as hydrochloride) | Oral | 56 | 5 | Strattera | |
| Capsule 80 mg (as hydrochloride) | Oral | 28 | 5 | Strattera | |
| Capsule 100 mg (as hydrochloride) | Oral | 28 | 5 | Strattera | |
| Atorvastatin [NP] | Tablet 10 mg (as calcium) | Oral | 30 | 5 | Lipitor |
| Tablet 20 mg (as calcium) | Oral | 30 | 5 | Lipitor | |
| Tablet 40 mg (as calcium) | Oral | 30 | 5 | Lipitor | |
| Tablet 80 mg (as calcium) | Oral | 30 | 5 | Lipitor | |
| Atovaquone [NP] | Oral suspension 750 mg per 5 mL, 210 mL | Oral | 1 | .. | Wellvone |
| Atovaquone with proguanil [NP] | Tablet containing atovaquone 250 mg with proguanil hydrochloride 100 mg | Oral | 12 | .. | Malarone |
| Atropine [NP] | Injection containing atropine sulfate 600 micrograms in 1 mL | Injection | 10 | 1 | AstraZeneca Pty Ltd |
| Eye drops containing atropine sulfate 10 mg per mL, 15 mL | Application to the eye | 1 | 2 | Atropt | |
| Auranofin [NP] | Tablet 3 mg | Oral | 60 | 5 | Ridaura |
| Aurothiomalate [NP] | Injection containing sodium aurothiomalate 10 mg | Injection | 10 | .. | Myocrisin |
| Injection containing sodium aurothiomalate 20 mg | Injection | 10 | 1 | Myocrisin | |
| Injection containing sodium aurothiomalate 50 mg | Injection | 10 | 1 | Myocrisin | |
| Azathioprine [NP] | Tablet 25 mg | Oral | 100 | 2 | Azahexal |
| Imuran | |||||
| Tablet 50 mg | Oral | 100 | 2 | Azamun | |
| Azapin | |||||
| Azathioprine Sandoz | |||||
| GenRx Azathioprine | |||||
| Imuran | |||||
| Thioprine | |||||
| Azithromycin [NP] | Tablet 500 mg (as dihydrate) | Oral | 2 | .. | Azithromycin Sandoz |
| Zithromax | |||||
| Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15 mL | Oral | 1 | .. | Zithromax | |
| Baclofen [NP] | Tablet 10 mg | Oral | 100 | 5 | Chem mart Baclofen |
| Clofen 10 | |||||
| GenRx Baclofen | |||||
| Lioresal 10 | |||||
| Stelax 10 | |||||
| Terry White Chemists Baclofen | |||||
| Tablet 25 mg | Oral | 100 | 5 | Chem mart Baclofen | |
| Clofen 25 | |||||
| GenRx Baclofen | |||||
| Lioresal 25 | |||||
| Stelax 25 | |||||
| Terry White Chemists Baclofen | |||||
| Balsalazide [NP] | Capsule containing balsalazide sodium 750 mg | Oral | 180 | 5 | Colazide |
| "BCG Immunotherapeutic" (Bacillus Calmette-Guérin/ Connaught strain) | Single dose set comprising 1 vial powder for intravesical administration containing 6.6 to 19.2 x 108 CFU and 1 vial diluent 3 mL | Intravesical | 3 | 1 | ImmuCyst |
| "BCG-Tice" (Bacillus Calmette-Guérin/ Tice strain) | Vial containing powder for intravesical administration approximately 5 x 108 CFU | Intravesical | 3 | 1 | OncoTICE |
| Beclomethasone [NP] | Pressurised inhalation containing beclomethasone dipropionate 50 micrograms per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | 1 | 5 | Qvar 50 |
| Pressurised inhalation containing beclomethasone dipropionate 100 micrograms per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | 1 | 5 | Qvar 100 | |
| Pressurised inhalation in breath actuated device containing beclomethasone dipropionate 50 micrograms per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | 1 | 5 | Qvar 50 Autohaler | |
| Pressurised inhalation in breath actuated device containing beclomethasone dipropionate 100 micrograms per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | 1 | 5 | Qvar 100 Autohaler | |
| Benzathine benzylpenicillin [NP] | Injection 900 mg in 2.3 mL single use pre-filled syringe | Injection | 10 | .. | Bicillin L-A |
| Benzhexol [NP] | Tablet containing benzhexol hydrochloride 2 mg | Oral | 200 | 2 | Artane |
| Tablet containing benzhexol hydrochloride 5 mg | Oral | 200 | 1 | Artane | |
| Benztropine [NP] | Tablet containing benztropine mesylate 2 mg | Oral | 60 | 2 | Benztrop |
| Injection containing benztropine mesylate 2 mg in 2 mL | Injection | 5 | .. | Cogentin | |
| Benzydamine [NP] | Mouth and throat rinse containing benzydamine hydrochloride 22.5 mg per 15 mL, 500 mL | Oral application | 1 | 1 | Difflam |
| Benzylpenicillin [NP] [MW] | Powder for injection 600 mg (as sodium) [MW] | Injection | 10 | 1 | BenPen |
| Powder for injection 3 g (as sodium) | Injection | 10 | .. | BenPen | |
| Betamethasone [NP] | Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL | Injection | 5 | .. | Celestone Chronodose |
| Cream 500 micrograms (as dipropionate) per g, 15 g | Application | 1 | 1 | Diprosone | |
| Eleuphrat | |||||
| Cream 200 micrograms (as valerate) per g, 100 g | Application | 2 | .. | Antroquoril | |
| Betnovate 1/5 | |||||
| Celestone-M | |||||
| Cortival 1/5 | |||||
| Ointment 500 micrograms (as dipropionate) per g, 15 g | Application | 1 | 1 | Diprosone | |
| Eleuphrat | |||||
| Cream 500 micrograms (as valerate) per g, 15 g | Application | 1 | 1 | Betnovate 1/2 | |
| Cortival 1/2 | |||||
| Ointment 200 micrograms (as valerate) per g, 100 g | Application | 2 | .. | Antroquoril | |
| Celestone-M | |||||
| Ointment 500 micrograms (as valerate) per g, 15 g | Application | 1 | 1 | Betnovate 1/2 | |
| Cortival 1/2 | |||||
| Betaxolol | Eye drops, suspension, 2.5 mg (as hydrochloride) per mL, 5 mL | Application to the eye | 1 | 5 | Betoptic S |
| Eye drops, solution, 5 mg (as hydrochloride) per mL, 5 mL | Application to the eye | 1 | 5 | Betoptic | |
| BetoQuin | |||||
| Bethanechol [NP] | Tablet containing bethanechol hydrochloride 10 mg | Oral | 100 | 2 | Uro-Carb |
| Bevacizumab | Solution for I.V. infusion 100 mg in 4 mL | Injection | 1 | .. | Avastin |
| Solution for I.V. infusion 400 mg in 16 mL | Injection | 1 | .. | Avastin | |
| Bicalutamide [NP] | Tablet 50 mg | Oral | 28 | 5 | APO-Bicalutamide |
| Bicalutamide-GA | |||||
| Bicalutamide Ranbaxy | |||||
| Calutex | |||||
| Cosamide | |||||
| Cosudex | |||||
| Bimatoprost | Eye drops 300 micrograms per mL, 3 mL | Application to the eye | 1 | 5 | Lumigan |
| Bimatoprost with timolol | Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, 3 mL | Application to the eye | 1 | 5 | Ganfort 0.3/5 |
| Biperiden [NP] | Tablet containing biperiden hydrochloride 2 mg | Oral | 200 | 2 | Akineton |
| Bisacodyl [NP] | Tablet 5 mg | Oral | 200 | 2 | Bisalax |
| Lax-Tab | |||||
| Suppositories 10 mg, 10 | Rectal | 3 | 5 | Dulcolax | |
| Petrus Bisacodyl Suppositories | |||||
| Suppositories 10 mg, 12 | Rectal | 3 | 4 | Petrus Bisacodyl Suppositories | |
| Enemas 10 mg in 5 mL, 25 | Rectal | 1 | 2 | Bisalax | |
| Bisoprolol [NP] | Tablet containing bisoprolol fumarate 2.5 mg | Oral | 28 | 5 | Bicor |
| Bisoprolol Sandoz | |||||
| Bispro 2.5 | |||||
| Tablet containing bisoprolol fumarate 5 mg | Oral | 28 | 5 | Bicor | |
| Bisoprolol Sandoz | |||||
| Bispro 5 | |||||
| Tablet containing bisoprolol fumarate 10 mg | Oral | 28 | 5 | Bicor | |
| Bisoprolol Sandoz | |||||
| Bispro 10 | |||||
| Bivalirudin | Powder for I.V. injection 250 mg (as trifluoroacetate) | Injection | 1 | .. | Angiomax |
| Bleomycin | Powder for injection containing bleomycin sulfate 15,000 I.U. (with any determined brand of sodium chloride injection as the required solvent) | Injection | 10 | .. | Blenamax |
| Blenoxane | |||||
| Hospira Pty Limited | |||||
| Bortezomib | Powder for injection 3.5 mg (with any determined brand of sodium chloride injection as the required solvent) | Injection | 4 | 2 | Velcade |
| Brimonidine | Eye drops containing brimonidine tartrate 1.5 mg per mL, 5 mL | Application to the eye | 1 | 5 | Alphagan P 1.5 |
| Eye drops containing brimonidine tartrate 2 mg per mL, 5 mL | Application to the eye | 1 | 5 | Alphagan | |
| Enidin | |||||
| Brimonidine with Timolol | Eye drops containing brimonidine tartrate 2 mg with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | 1 | 5 | Combigan |
| Brinzolamide | Eye drops 10 mg per mL, 5 mL | Application to the eye | 1 | 5 | Azopt |
| BrinzoQuin | |||||
| Brinzolamide with timolol | Eye drops 10 mg brinzolamide with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | 1 | 5 | Azarga |
| Bromocriptine [NP] | Tablet 2.5 mg (as mesylate) [NP] | Oral | 30 | .. | Kripton 2.5 |
| Parlodel | |||||
| Capsule 5 mg (as mesylate) | Oral | 60 | 5 | Kripton 5 | |
| Parlodel | |||||
| Capsule 10 mg (as mesylate) | Oral | 100 | 5 | Kripton 10 | |
| Parlodel | |||||
| Budesonide [NP] | Nebuliser suspension 500 micrograms in 2 mL single dose units, 30 | Inhalation | 1 | 5 | Pulmicort Respules |
| Nebuliser suspension 1 mg in 2 mL single dose units, 30 | Inhalation | 1 | 5 | Pulmicort Respules | |
| Powder for oral inhalation in breath actuated device 100 micrograms per dose, 200 doses | Inhalation by mouth | 1 | 5 | Pulmicort Turbuhaler | |
| Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses | Inhalation by mouth | 1 | 5 | Pulmicort Turbuhaler | |
| Powder for oral inhalation in breath actuated device 400 micrograms per dose, 200 doses | Inhalation by mouth | 1 | 5 | Pulmicort Turbuhaler | |
| Budesonide with Eformoterol [NP] | Powder for oral inhalation in breath actuated device containing budesonide 100 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth | 1 | 5 | Symbicort Turbuhaler 100/6 |
| Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth | 1 | 5 | Symbicort Turbuhaler 200/6 | |
| Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with eformoterol fumarate dihydrate 12 micrograms per dose, 60 doses, 2 | Inhalation by mouth | 1 | 5 | Symbicort Turbuhaler 400/12 | |
| Buprenorphine [NP] | Transdermal patch 5 mg | Transdermal | 2 | .. | Norspan |
| Transdermal patch 10 mg | Transdermal | 2 | .. | Norspan | |
| Transdermal patch 20 mg | Transdermal | 2 | .. | Norspan | |
| Bupropion [NP] | Tablet containing bupropion hydrochloride 150 mg (sustained release) | Oral | 30 | .. | Clorprax |
| Prexaton | |||||
| Zyban | |||||
| Busulfan | Tablet 2 mg | Oral | 100 | .. | Myleran |
| Cabergoline [NP] | Tablet 500 micrograms | Oral | 2 | .. | Dostinex |
| Tablet 1 mg | Oral | 30 | 5 | Bergoline 1 | |
| Cabaser | |||||
| Tablet 2 mg | Oral | 30 | 5 | Bergoline 2 | |
| Cabaser | |||||
| Calcipotriol [NP] | Cream 50 micrograms (as monohydrate) per g, 30 g | Application | 1 | 1 | Daivonex |
| Scalp solution 50 micrograms (as monohydrate) per mL, 30 mL | Application | 1 | 1 | Daivonex | |
| Calcipotriol with betamethasone [NP] | Ointment containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 30 g | Application | 1 | 1 | Daivobet |
| Calcitriol [NP] | Capsule 0.25 microgram | Oral | 100 | 3 | Calcitriol-DP |
| Calcitriol-GA | |||||
| Calcitriol Sandoz | |||||
| GenRx Calcitriol | |||||
| Kosteo | |||||
| Rocaltrol | |||||
| Sical | |||||
| Calcium [NP] | Tablet, chewable, 500 mg (as carbonate) | Oral | 240 | 1 | Cal-Sup |
| Tablet 600 mg (as carbonate) | Oral | 240 | 1 | Calci-Tab 600 | |
| Candesartan [NP] | Tablet containing candesartan cilexetil 4 mg | Oral | 30 | 5 | Atacand |
| Tablet containing candesartan cilexetil 8 mg | Oral | 30 | 5 | Atacand | |
| Tablet containing candesartan cilexetil 16 mg | Oral | 30 | 5 | Atacand | |
| Tablet containing candesartan cilexetil 32 mg | Oral | 30 | 5 | Atacand | |
| Candesartan with Hydrochlorothiazide [NP] | Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg | Oral | 30 | 5 | Atacand Plus 16/12.5 |
| Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg | Oral | 30 | 5 | Atacand Plus 32/12.5 | |
| Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg | Oral | 30 | 5 | Atacand Plus 32/25 | |
| Capecitabine | Tablet 150 mg | Oral | 60 | 2 | Xeloda |
| Tablet 500 mg | Oral | 120 | 2 | Xeloda | |
| Captopril [NP] | Tablet 12.5 mg | Oral | 90 | 5 | Captopril Sandoz |
| GenRx Captopril | |||||
| Zedace | |||||
| Tablet 25 mg | Oral | 90 | 5 | Ascent Pharma Pty Ltd | |
| Capoten | |||||
| Captopril Sandoz | |||||
| GenRx Captopril | |||||
| Zedace | |||||
| Tablet 50 mg | Oral | 90 | 5 | Ascent Pharma Pty Ltd | |
| Capoten | |||||
| Captopril Sandoz | |||||
| GenRx Captopril | |||||
| Zedace | |||||
| Oral solution 5 mg per mL, 95 mL | Oral | 1 | 5 | ||
| Carbamazepine [NP] | Tablet 100 mg | Oral | 200 | 2 | Carbamazepine Sandoz |
| Tegretol 100 | |||||
| Tablet 200 mg | Oral | 200 | 2 | Carbamazepine Sandoz | |
| Tegretol 200 | |||||
| Teril | |||||
| Tablet 200 mg (controlled release) | Oral | 200 | 2 | Tegretol CR 200 | |
| Tablet 400 mg (controlled release) | Oral | 200 | 2 | Tegretol CR 400 | |
| Oral suspension 100 mg per 5 mL, 300 mL | Oral | 1 | 5 | Tegretol Liquid | |
| Carbimazole [NP] | Tablet 5 mg | Oral | 200 | 2 | Neo-Mercazole |
| Carbohydrate, fat, vitamins, minerals and trace elements [NP] | Oral powder 400 g (Energivit) | Oral | 8 | 5 | Energivit |
| Carbomer [NP] | Eye gel 2 mg per g, 10 g | Application to the eye | 1 | 5 | GelTears |
| PAA | |||||
| Viscotears | |||||
| Eye gel 2 mg per g, single dose units 0.6 mL, 30 | Application to the eye | 3 | 5 | Viscotears | |
| Carbomer 974 [NP] | Ocular lubricating gel 3 mg per g, single dose units 0.5 g, 30 | Application to the eye | 3 | 5 | Poly Gel |
| Carboplatin | Solution for I.V. injection 50 mg in 5 mL | Injection | 2 | .. | Carboplatin Ebewe |
| Hospira Pty Limited | |||||
| Pfizer Australia Pty Ltd | |||||
| Solution for I.V. injection 150 mg in 15 mL | Injection | 6 | .. | Carboplatin Ebewe | |
| Hospira Pty Limited | |||||
| Pfizer Australia Pty Ltd | |||||
| Solution for I.V. injection 450 mg in 45 mL | Injection | 2 | .. | Carboplatin Ebewe | |
| Hospira Pty Limited | |||||
| Pfizer Australia Pty Ltd | |||||
| Carmellose [NP] | Eye drops containing carmellose sodium 5 mg per mL, 15 mL | Application to the eye | 1 | 5 | Refresh Tears Plus |
| Eye drops containing carmellose sodium 10 mg per mL, 15 mL | Application to the eye | 1 | 5 | Refresh Liquigel | |
| Eye drops containing carmellose sodium 2.5 mg per mL, single dose units 0.6 mL, 24 | Application to the eye | 4 | 5 | TheraTears | |
| Eye drops containing carmellose sodium 5 mg per mL, single dose units 0.4 mL, 30 | Application to the eye | 3 | 5 | Cellufresh | |
| Eye drops containing carmellose sodium 10 mg per mL, single dose units 0.4 mL, 30 | Application to the eye | 3 | 5 | Celluvisc | |
| Ocular lubricating gel containing carmellose sodium 10 mg per mL, single dose units 0.6 mL, 28 | Application to the eye | 3 | 5 | TheraTears | |
| Carmellose with glycerin [NP] | Eye drops containing carmellose sodium 5 mg with glycerin 9 mg per mL, 15 mL | Application to the eye | 1 | 3 | Optive |
| Eye drops containing carmellose sodium 5 mg with glycerin 9 mg per mL, single dose units 0.4 mL, 30 | Application to the eye | 3 | 5 | Optive | |
| Carmustine | Implants 7.7 mg, 8 | Implantation | 1 | .. | Gliadel |
| Carvedilol [NP] | Tablet 3.125 mg | Oral | 30 | .. | Chem mart Carvedilol 3.125 mg |
| Dilasig 3.125 | |||||
| Dilatrend 3.125 | |||||
| GenRx Carvedilol | |||||
| GN-Carvedilol | |||||
| Kredex | |||||
| Terry White Chemists Carvedilol 3.125 mg | |||||
| Vedilol 3.125 | |||||
| Tablet 6.25 mg | Oral | 60 | 5 | APO-Carvedilol | |
| Carvedilol generichealth | |||||
| Carvedilol Sandoz | |||||
| Chem mart Carvedilol 6.25 mg | |||||
| Dicarz | |||||
| Dilasig 6.25 | |||||
| Dilatrend 6.25 | |||||
| GenRx Carvedilol | |||||
| GN-Carvedilol | |||||
| Kredex | |||||
| Terry White Chemists Carvedilol 6.25 mg | |||||
| Vedilol 6.25 | |||||
| Tablet 12.5 mg | Oral | 60 | 5 | APO-Carvedilol | |
| Carvedilol generichealth | |||||
| Carvedilol Sandoz | |||||
| Chem mart Carvedilol 12.5 mg | |||||
| Dicarz | |||||
| Dilasig 12.5 | |||||
| Dilatrend 12.5 | |||||
| GenRx Carvedilol | |||||
| GN-Carvedilol | |||||
| Kredex | |||||
| Terry White Chemists Carvedilol 12.5 mg | |||||
| Vedilol 12.5 | |||||
| Tablet 25 mg | Oral | 60 | 5 | APO-Carvedilol | |
| Carvedilol generichealth | |||||
| Carvedilol Sandoz | |||||
| Chem mart Carvedilol 25 mg | |||||
| Dicarz | |||||
| Dilasig 25 | |||||
| Dilatrend 25 | |||||
| GenRx Carvedilol | |||||
| GN-Carvedilol | |||||
| Kredex | |||||
| Terry White Chemists Carvedilol 25 mg | |||||
| Vedilol 25 | |||||
| Cefaclor | Tablet (sustained release) 375 mg (as monohydrate) | Oral | 10 | 1 | Ceclor CD |
| Cefaclor-GA | |||||
| Chem mart Cefaclor CD | |||||
| Douglas Cefaclor-CD | |||||
| GenRx Cefaclor CD | |||||
| Karlor CD | |||||
| Keflor CD | |||||
| Ozcef | |||||
| Terry White Chemists Cefaclor CD | |||||
| Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL | Oral | 1 | 1 | Aclor 125 | |
| Ceclor | |||||
| Cefaclor Sandoz | |||||
| Chem mart Cefaclor | |||||
| GenRx Cefaclor | |||||
| Keflor | |||||
| Ozcef | |||||
| Terry White Chemists Cefaclor | |||||
| Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL | Oral | 1 | 1 | Aclor 250 | |
| Ceclor | |||||
| Cefaclor Sandoz | |||||
| Chem mart Cefaclor | |||||
| GenRx Cefaclor | |||||
| Keflor | |||||
| Ozcef | |||||
| Terry White Chemists Cefaclor | |||||
| Cefalotin [NP] | Powder for injection 1 g (as sodium) | Injection | 10 | 1 | Cefalotin Sandoz |
| Hospira Pty Limited | |||||
| Keflin Neutral | |||||
| Cefepime [NP] | Powder for injection 1 g (as hydrochloride) (with any determined brand of sodium chloride injection as the required solvent) | Injection | 10 | .. | Maxipime |
| Powder for injection 2 g (as hydrochloride) (with any determined brand of sodium chloride injection as the required solvent) | Injection | 10 | .. | Maxipime | |
| Cefotaxime [NP] | Powder for injection 1 g (as sodium) | Injection | 10 | .. | Cefotaxime Sandoz |
| Hospira Pty Limited | |||||
| Powder for injection 2 g (as sodium) | Injection | 10 | .. | Cefotaxime Sandoz | |
| Hospira Pty Limited | |||||
| Ceftriaxone [NP] | Powder for injection 500 mg (as sodium) | Injection | 1 | .. | Ceftriaxone ICP |
| Powder for injection 1 g (as sodium) | Injection | 5 | .. | Ceftriaxone ICP | |
| Ceftriaxone Sandoz | |||||
| DBL Ceftriaxone | |||||
| Max Pharma Pty Ltd | |||||
| Rocephin | |||||
| Powder for injection 2 g (as sodium) | Injection | 5 | .. | Ceftriaxone ICP | |
| Ceftriaxone Sandoz | |||||
| DBL Ceftriaxone | |||||
| Rocephin | |||||
| Cefuroxime | Tablet 250 mg (as axetil) | Oral | 14 | 1 | Zinnat |
| Celecoxib [NP] | Capsule 100 mg | Oral | 60 | 3 | Celebrex |
| Capsule 200 mg | Oral | 30 | 3 | Celebrex | |
| Cephalexin [NP] [MW] | Capsule 250 mg (anhydrous) [MW] | Oral | 20 | 1 | Cefalexin Sandoz |
| Cephabell | |||||
| Cephalexin generichealth | |||||
| Cephatrust 250 | |||||
| Chem mart Cephalexin | |||||
| Cilex | |||||
| GenRx Cephalexin | |||||
| Ialex | |||||
| Ibilex 250 | |||||
| Keflex | |||||
| Rancef | |||||
| Terry White Chemists Cephalexin | |||||
| Capsule 500 mg (anhydrous) [MW] | Oral | 20 | 1 | Cefalexin Sandoz | |
| Cephabell | |||||
| Cephalexin generichealth | |||||
| Cephatrust 500 | |||||
| Chem mart Cephalexin | |||||
| Cilex | |||||
| GenRx Cephalexin | |||||
| Ialex | |||||
| Ibilex 500 | |||||
| Keflex | |||||
| Rancef | |||||
| Terry White Chemists Cephalexin | |||||
| Granules for oral suspension 125 mg per 5 mL, 100 mL | Oral | 1 | 1 | APO-Cephalexin | |
| Cefalexin Sandoz | |||||
| Chem mart Cephalexin | |||||
| Cilex | |||||
| GenRx Cephalexin | |||||
| Ialex | |||||
| Ibilex 125 | |||||
| Keflex | |||||
| Terry White Chemists Cephalexin | |||||
| Granules for oral suspension 250 mg per 5 mL, 100 mL | Oral | 1 | 1 | APO-Cephalexin | |
| Cefalexin Sandoz | |||||
| Chem mart Cephalexin | |||||
| Cilex | |||||
| GenRx Cephalexin | |||||
| Ialex | |||||
| Ibilex 250 | |||||
| Keflex | |||||
| Terry White Chemists Cephalexin | |||||
| Cephazolin [NP] | Powder for injection 500 mg (as sodium) | Injection | 10 | .. | Hospira Pty Limited |
| Powder for injection 1 g (as sodium) | Injection | 10 | .. | Cefazolin Sandoz | |
| Hospira Pty Limited | |||||
| Kefzol | |||||
| Powder for injection 2 g (as sodium) | Injection | 10 | .. | Cefazolin Sandoz | |
| Certolizumab pegol | Injection 200 mg in 1 mL single use pre-filled syringe | Injection | 2 | 5 | Cimzia |
| Cetuximab | Solution for I.V. infusion 100 mg in 20 mL | Injection | 1 | .. | Erbitux |
| Solution for I.V. infusion 500 mg in 100 mL | Injection | 1 | .. | Erbitux | |
| Chlorambucil | Tablet 2 mg | Oral | 100 | 2 | Leukeran |
| Chloramphenicol [NP] [MW] | Ear drops (aqueous) 5 mg per mL, 5 mL | Application to the ear | 1 | 2 | Chloromycetin |
| Eye drops 5 mg per mL, 10 mL [MW] | Application to the eye | 1 | 2 | Chloromycetin | |
| Chlorsig | |||||
| Eye ointment 10 mg per g, 4 g [MW] | Application to the eye | 1 | .. | Chloromycetin | |
| Chlorsig | |||||
| Chlorpromazine [NP] | Tablet containing chlorpromazine hydrochloride 10 mg | Oral | 100 | 5 | Largactil |
| Tablet containing chlorpromazine hydrochloride 25 mg | Oral | 100 | 5 | Largactil | |
| Tablet containing chlorpromazine hydrochloride 100 mg | Oral | 100 | 5 | Largactil | |
| Oral solution containing chlorpromazine hydrochloride 25 mg per 5 mL, 100 mL | Oral | 1 | 5 | Largactil | |
| Injection containing chlorpromazine hydrochloride 50 mg in 2 mL | Injection | 10 | .. | Largactil | |
| Chlorthalidone [NP] | Tablet 25 mg | Oral | 100 | 1 | Hygroton 25 |
| Cholestyramine [NP] | Sachets containing 4.7 g oral powder (equivalent to 4 g cholestyramine), 50 | Oral | 2 | 5 | Questran Lite |
| Chorionic Gonadotrophin | Injection set containing 3 ampoules powder for injection 1,500 units and 3 ampoules solvent 1 mL | Injection | 1 | 5 | Pregnyl |
| Ciclesonide [NP] | Pressurised inhalation 80 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | 1 | 5 | Alvesco 80 |
| Pressurised inhalation 160 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | 1 | 5 | Alvesco 160 | |
| Cimetidine [NP] | Tablet 200 mg | Oral | 120 | 5 | Magicul 200 |
| Tablet 400 mg | Oral | 60 | 5 | GenRx Cimetidine | |
| Magicul 400 | |||||
| Tablet 800 mg | Oral | 30 | 5 | GenRx Cimetidine | |
| Magicul 800 | |||||
| Cinacalcet [NP] | Tablet 30 mg (as hydrochloride) | Oral | 28 | 5 | Sensipar |
| Tablet 60 mg (as hydrochloride) | Oral | 28 | 5 | Sensipar | |
| Tablet 90 mg (as hydrochloride) | Oral | 28 | 5 | Sensipar | |
| Ciprofloxacin [NP] | Tablet 250 mg (as hydrochloride) | Oral | 14 | .. | C-Flox 250 |
| Cifran | |||||
| Ciprofloxacin-DRLA | |||||
| Ciprofloxacin Sandoz | |||||
| Ciprol 250 | |||||
| Ciproxin 250 | |||||
| GenRx Ciprofloxacin | |||||
| Profloxin | |||||
| Tablet 500 mg (as hydrochloride) | Oral | 14 | .. | Ascent Pharmaceuticals Limited | |
| C-Flox 500 | |||||
| Cifran | |||||
| Ciprofloxacin 500 | |||||
| Ciprofloxacin-BW | |||||
| Ciprofloxacin-DRLA | |||||
| Ciprofloxacin-GA | |||||
| Ciprofloxacin Sandoz | |||||
| Ciprol 500 | |||||
| Ciproxin 500 | |||||
| GenRx Ciprofloxacin | |||||
| Tablet 750 mg (as hydrochloride) | Oral | 14 | .. | Ascent Pharmaceuticals Limited | |
| C-Flox 750 | |||||
| Cifran | |||||
| Ciprofloxacin 750 | |||||
| Ciprofloxacin-BW | |||||
| Ciprofloxacin-DRLA | |||||
| Ciprofloxacin-GA | |||||
| Ciprofloxacin Sandoz | |||||
| Ciprol 750 | |||||
| Ciproxin 750 | |||||
| GenRx Ciprofloxacin | |||||
| Ear drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the ear | 1 | 1 | Ciloxan | |
| Eye drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the eye | 2 | .. | CiloQuin | |
| Ciloxan | |||||
| Cisplatin | I.V. injection 10 mg in 10 mL | Injection | 1 | .. | Pfizer Australia Pty Ltd |
| I.V. injection 50 mg in 50 mL | Injection | 1 | .. | Hospira Pty Limited | |
| Pfizer Australia Pty Ltd | |||||
| I.V. injection 100 mg in 100 mL | Injection | 1 | .. | Cisplatin Ebewe | |
| Hospira Pty Limited | |||||
| Pfizer Australia Pty Ltd | |||||
| Citalopram [NP] | Tablet 10 mg (as hydrobromide) | Oral | 28 | 5 | Celapram |
| Tablet 20 mg (as hydrobromide) | Oral | 28 | 5 | APO-Citalopram | |
| Celapram | |||||
| Celica | |||||
| Chem mart Citalopram | |||||
| Ciazil | |||||
| Cipramil | |||||
| Citalobell | |||||
| Citalopram 20 | |||||
| Citalopram generichealth | |||||
| Citalopram Sandoz | |||||
| GenRx Citalopram | |||||
| Talam | |||||
| Terry White Chemists Citalopram | |||||
| Tablet 40 mg (as hydrobromide) | Oral | 28 | 5 | APO-Citalopram | |
| Celapram | |||||
| Citalopram Sandoz | |||||
| GenRx Citalopram | |||||
| Cladribine | Injection 10 mg in 5 mL | Injection | 7 | .. | Litak |
| Solution for I.V. infusion 10 mg in 10 mL single use vial | Injection | 7 | .. | Leustatin | |
| Clarithromycin [NP] | Tablet 250 mg | Oral | 14 | 1 | APO-Clarithromycin |
| Chem mart Clarithromycin | |||||
| Clarac | |||||
| Clarihexal | |||||
| Clarithro 250 | |||||
| GenRx Clarithromycin | |||||
| Kalixocin | |||||
| Klacid | |||||
| Terry White Chemists Clarithromycin | |||||
| Powder for oral liquid 250 mg per 5 mL, 50 mL | Oral | 1 | .. | Klacid | |
| Clindamycin [NP] [MW] | Capsule 150 mg (as hydrochloride) | Oral | 24 | .. | Cleocin |
| Dalacin C | |||||
| Clodronic Acid [NP] | Capsule containing 400 mg sodium clodronate (as tetrahydrate) | Oral | 100 | 2 | Bonefos |
| Capsule containing 800 mg sodium clodronate (as tetrahydrate) | Oral | 60 | 2 | Bonefos 800 mg | |
| Clomiphene | Tablet containing clomiphene citrate 50 mg | Oral | 10 | 5 | Clomid |
| Serophene | |||||
| Clomipramine [NP] | Tablet containing clomipramine hydrochloride 25 mg | Oral | 50 | 2 | Anafranil 25 |
| Chem mart Clomipramine | |||||
| GenRx Clomipramine | |||||
| Placil | |||||
| Terry White Chemists Clomipramine | |||||
| Clonazepam [NP] | Tablet 500 micrograms | Oral | 200 | 2 | Paxam 0.5 |
| Rivotril | |||||
| Tablet 2 mg | Oral | 200 | 2 | Paxam 2 | |
| Rivotril | |||||
| Oral liquid 2.5 mg per mL, 10 mL | Oral | 2 | .. | Rivotril | |
| Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent) | Injection | 5 | .. | Rivotril | |
| Clonidine [NP] | Tablet containing clonidine hydrochloride 100 micrograms | Oral | 100 | 5 | Catapres 100 |
| Tablet containing clonidine hydrochloride 150 micrograms | Oral | 100 | 5 | Catapres | |
| Clopidogrel [NP] | Tablet 75 mg (as hydrogen sulfate) | Oral | 28 | 5 | APO-Clopidogrel |
| Chem mart Clopidogrel | |||||
| Clopidogrel Sandoz | |||||
| Clopidogrel Winthrop | |||||
| Iscover | |||||
| Piax | |||||
| Plavix | |||||
| Terry White Chemists Clopidogrel | |||||
| Tablet 75 mg (as besilate) | Oral | 28 | 5 | Clovix 75 | |
| Clopidogrel with aspirin [NP] | Tablet 75 mg (as hydrogen sulfate)-100 mg | Oral | 30 | 5 | CoPlavix |
| DuoCover | |||||
| Clotrimazole [NP] | Cream 10 mg per g, 20 g | Application | 2 | 3 | Clonea |
| Coal Tar - Prepared [NP] | Gel 10 mg per g, 100 mL | Application | 1 | 2 | Exorex |
| Codeine | Tablet containing codeine phosphate 30 mg | Oral | 20 | .. | Fawns and McAllan Proprietary Limited |
| Codeine with Paracetamol [NP] | Tablet containing codeine phosphate 30 mg with paracetamol 500 mg | Oral | 20 | .. | APO- Paracetamol/Codeine 500/30 |
| Codalgin Forte | |||||
| Codapane Forte | |||||
| Comfarol Forte | |||||
| Dolaforte | |||||
| Panadeine Forte | |||||
| Prodeine Forte | |||||
| Colchicine [NP] | Tablet 500 micrograms | Oral | 100 | 2 | Colgout |
| Lengout | |||||
| Tablets 500 micrograms, 30 | Oral | 1 | 2 | Colgout | |
| Lengout | |||||
| Colestipol [NP] | Oral powder, sachets containing colestipol hydrochloride 5 g, 120 | Oral | 1 | 5 | Colestid |
| Copper Sulfate [NP] | Tablets, diagnostic compound, 36 | For external use | 2 | 3 | Clinitest |
| Cortisone [NP] | Tablet containing cortisone acetate 5 mg | Oral | 50 | 4 | Cortate |
| Tablet containing cortisone acetate 25 mg | Oral | 60 | 4 | Cortate | |
| Cromoglycic Acid [NP] | Capsule containing powder for oral inhalation containing sodium cromoglycate 20 mg (for use in Intal Spinhaler or Intal Halermatic) | Inhalation by mouth | 100 | 5 | Intal Spincaps |
| Pressurised inhalation containing sodium cromoglycate 1 mg per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | 1 | 5 | Intal CFC-Free | |
| Pressurised inhalation containing sodium cromoglycate 5 mg per dose, 112 doses (CFC-free formulation) | Inhalation by mouth | 1 | 5 | Intal Forte CFC-Free | |
| Eye drops containing sodium cromoglycate 20 mg per mL, 10 mL | Application to the eye | 1 | 5 | Cromolux | |
| Opticrom | |||||
| Cyclophosphamide | Tablet 50 mg | Oral | 50 | 2 | Cycloblastin |
| Powder for injection 500 mg (anhydrous) (with any determined brand of sodium chloride injection as the required solvent) | Injection | 2 | .. | Endoxan | |
| Powder for injection 1 g (anhydrous) (with any determined brand of sodium chloride injection as the required solvent) | Injection | 1 | .. | Endoxan | |
| Powder for injection 2 g (anhydrous) (with any determined brand of sodium chloride injection as the required solvent) | Injection | 1 | .. | Endoxan | |
| Cyclosporin | Capsule 10 mg | Oral | 120 | 3 | Neoral 10 |
| Capsule 25 mg | Oral | 60 | 3 | Cicloral | |
| Neoral 25 | |||||
| Capsule 50 mg | Oral | 60 | 3 | Cicloral | |
| Neoral 50 | |||||
| Capsule 100 mg | Oral | 60 | 3 | Cicloral | |
| Neoral 100 | |||||
| Oral liquid 100 mg per mL, 50 mL | Oral | 2 | 3 | Neoral | |
| Cyproheptadine [NP] | Tablet containing cyproheptadine hydrochloride 4 mg (anhydrous) | Oral | 100 | 2 | Periactin |
| Cyproterone | Tablet containing cyproterone acetate 50 mg | Oral | 20 | 5 | Androcur |
| Cyprohexal | |||||
| Cyprone | |||||
| Cyprostat | |||||
| GenRx Cyproterone Acetate | |||||
| Procur | |||||
| Tablet containing cyproterone acetate 100 mg | Oral | 50 | 5 | Androcur-100 | |
| Cyprohexal | |||||
| Cyprostat-100 | |||||
| GenRx Cyproterone Acetate | |||||
| Procur 100 | |||||
| Cystine with carbohydrate [NP] | Sachets of oral powder 4 g containing 500 mg cystine, 30 (Cystine Amino Acid Supplement) | Oral | 4 | 5 | Cystine Amino Acid Supplement |
| Cytarabine | Injection 100 mg in 5 mL vial | Injection | 10 | 1 | Pfizer Australia Pty Ltd |
| Dabigatran etexilate [NP] | Capsules 75 mg (as mesilate), 60 | Oral | 1 | .. | Pradaxa |
| Capsules 110 mg (as mesilate), 60 | Oral | 1 | .. | Pradaxa | |
| Capsule 75 mg (as mesilate) | Oral | 20 | .. | Pradaxa | |
| Capsule 110 mg (as mesilate) | Oral | 20 | .. | Pradaxa | |
| Dalteparin [NP] | Injection containing dalteparin sodium 2,500 I.U. (anti-Xa) in 0.2 mL single dose pre-filled syringe | Injection | 10 | 1 | Fragmin |
| Injection containing dalteparin sodium 5,000 I.U. (anti-Xa) in 0.2 mL single dose pre-filled syringe | Injection | 10 | 1 | Fragmin | |
| Injection containing dalteparin sodium 7,500 I.U. (anti-Xa) in 0.75 mL single dose pre-filled syringe | Injection | 10 | 1 | Fragmin | |
| Injection containing dalteparin sodium 10,000 I.U. (anti-Xa) in 1 mL single dose pre-filled syringe | Injection | 10 | 1 | Fragmin | |
| Danazol | Capsule 100 mg | Oral | 100 | 5 | Azol 100 |
| Capsule 200 mg | Oral | 100 | 5 | Azol 200 | |
| Dantrolene [NP] | Capsule containing dantrolene sodium 25 mg | Oral | 100 | 2 | Dantrium |
| Capsule containing dantrolene sodium 50 mg | Oral | 100 | 2 | Dantrium | |
| Dapsone [NP] | Tablet 25 mg | Oral | 100 | 1 | Link Medical Products Pty Ltd |
| Tablet 100 mg | Oral | 100 | 1 | Link Medical Products Pty Ltd | |
| Dasatinib | Tablet 20 mg | Oral | 60 | 2 | Sprycel |
| Tablet 50 mg | Oral | 60 | 2 | Sprycel | |
| Tablet 70 mg | Oral | 60 | 2 | Sprycel | |
| Tablet 100 mg | Oral | 30 | 2 | Sprycel | |
| Desmopressin [NP] | Intranasal solution containing desmopressin acetate 100 micrograms per mL, 2.5 mL dropper bottle | Nasal | 5 | 5 | Minirin |
| Tablet containing desmopressin acetate 200 micrograms [NP] | Oral | 30 | 5 | Minirin | |
| Wafer 120 micrograms (as acetate) [NP] | Sublingual | 30 | 5 | Minirin Melt | |
| Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 60 actuations, 6 mL [NP] | Nasal | 1 | 5 | Minirin Nasal Spray | |
| Desvenlafaxine [NP] | Tablet (extended release) 50 mg (as succinate) | Oral | 28 | 5 | Pristiq |
| Tablet (extended release) 100 mg (as succinate) | Oral | 28 | 5 | Pristiq | |
| Dexamethasone [NP] | Tablet 500 micrograms | Oral | 30 | 4 | Dexmethsone |
| Tablet 4 mg | Oral | 30 | 4 | Dexmethsone | |
| Injection containing dexamethasone sodium phosphate equivalent to 4 mg dexamethasone phosphate in 1 mL | Injection | 5 | .. | Hospira Pty Limited | |
| Injection containing dexamethasone sodium phosphate equivalent to 8 mg dexamethasone phosphate in 2 mL | Injection | 5 | 1 | Hospira Pty Limited | |
| Eye drops 1 mg per mL, 5 mL | Application to the eye | 1 | 2 | Maxidex | |
| Dexamethasone with Framycetin and Gramicidin [NP] | Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL | Application to the ear | 1 | 2 | Otodex |
| Sofradex | |||||
| Dexamphetamine [NP] | Tablet containing dexamphetamine sulfate 5 mg | Oral | 100 | 5 | Sigma Pharmaceuticals (Australia) Pty Ltd |
| Diazepam [NP] | Tablet 2 mg | Oral | 50 | .. | Antenex 2 |
| Valium | |||||
| Valpam 2 | |||||
| Tablet 5 mg | Oral | 50 | .. | Antenex 5 | |
| Diazepam-GA | |||||
| Ranzepam | |||||
| Valium | |||||
| Valpam 5 | |||||
| Injection 10 mg in 2 mL | Injection | 5 | .. | Hospira Pty Limited | |
| Diclofenac [NP] [MW] | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | 100 | 3 | APO-Diclofenac |
| Chem mart Diclofenac | |||||
| Clonac 25 | |||||
| Diclofenac-GA | |||||
| Diclofenac Sandoz | |||||
| Fenac 25 | |||||
| Terry White Chemists Diclofenac | |||||
| Voltaren 25 | |||||
| Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | 50 | 3 | APO-Diclofenac | |
| Chem mart Diclofenac | |||||
| Clonac 50 | |||||
| Diclofenac-GA | |||||
| Diclofenac Sandoz | |||||
| Fenac | |||||
| Terry White Chemists Diclofenac | |||||
| Voltaren 50 | |||||
| Suppository containing diclofenac sodium 100 mg [MW] | Rectal | 40 | 3 | Voltaren 100 | |
| Dicloxacillin [NP] [MW] | Capsule 250 mg (as sodium) | Oral | 24 | .. | Dicloxsig |
| Distaph 250 | |||||
| Capsule 500 mg (as sodium) | Oral | 24 | .. | Diclocil | |
| Dicloxsig | |||||
| Distaph 500 | |||||
| Digoxin [NP] | Tablet 62.5 micrograms | Oral | 200 | 1 | Lanoxin-PG |
| Sigmaxin-PG | |||||
| Tablet 250 micrograms | Oral | 100 | 1 | Lanoxin | |
| Sigmaxin | |||||
| Paediatric oral solution 50 micrograms per mL, 60 mL | Oral | 2 | 3 | Lanoxin | |
| Dihydroergotamine [NP] | Injection containing dihydroergotamine mesylate 1 mg in 1 mL | Injection | 5 | .. | Dihydergot |
| Diltiazem [NP] | Tablet containing diltiazem hydrochloride 60 mg | Oral | 90 | 5 | Cardizem |
| Chem mart Diltiazem | |||||
| Coras | |||||
| Diltiazem Sandoz | |||||
| Dilzem 60 mg | |||||
| GenRx Diltiazem | |||||
| Terry White Chemists Diltiazem | |||||
| Vasocardol | |||||
| Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral | 30 | 5 | Cardizem CD | |
| Chem mart Diltiazem CD | |||||
| Diltahexal CD | |||||
| Dilzem CD | |||||
| GenRx Diltiazem CD | |||||
| Terry White Chemists Diltiazem CD | |||||
| Vasocardol CD | |||||
| Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral | 30 | 5 | Cardizem CD | |
| Chem mart Diltiazem CD | |||||
| Diltahexal CD | |||||
| Dilzem CD | |||||
| GenRx Diltiazem CD | |||||
| Terry White Chemists Diltiazem CD | |||||
| Vasocardol CD | |||||
| Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral | 30 | 5 | Cardizem CD | |
| Diltahexal CD | |||||
| Vasocardol CD | |||||
| Diphenoxylate with Atropine [NP] | Tablet containing diphenoxylate hydrochloride 2.5 mg with atropine sulfate 25 micrograms | Oral | 20 | .. | Lofenoxal |
| Lomotil | |||||
| Diphtheria and tetanus vaccine, adsorbed, diluted for adult use [NP] | Injection 0.5 mL in pre-filled syringe | Injection | 5 | .. | ADT Booster |
| Dipyridamole [NP] | Capsule 200 mg (sustained release) | Oral | 60 | 5 | Persantin SR |
| Dipyridamole with Aspirin [NP] | Capsule 200 mg (sustained release)-25 mg | Oral | 60 | 5 | Asasantin SR |
| Disopyramide [NP] | Capsule 100 mg | Oral | 100 | 5 | Rythmodan |
| Capsule 150 mg | Oral | 100 | 5 | Rythmodan | |
| Docetaxel | Injection set containing 1 single use vial concentrate for I.V. infusion 20 mg (anhydrous) in 0.5 mL with solvent | Injection | 1 | .. | Taxotere |
| Injection set containing 1 single use vial concentrate for I.V. infusion 80 mg (anhydrous) in 2 mL with solvent | Injection | 1 | .. | Taxotere | |
| Dolasetron [NP] | Tablet containing dolasetron mesylate 200 mg | Oral | 2 | .. | Anzemet |
| I.V. injection containing dolasetron mesylate 100 mg in 5 mL | Injection | 1 | .. | Anzemet | |
| Domperidone [NP] | Tablet 10 mg | Oral | 25 | .. | Motilium |
| Donepezil [NP] | Tablet containing donepezil hydrochloride 5 mg | Oral | 28 | 5 | Aricept |
| Tablet containing donepezil hydrochloride 10 mg | Oral | 28 | 5 | Aricept | |
| Dorzolamide | Eye drops 20 mg (as hydrochloride) per mL, 5 mL | Application to the eye | 1 | 5 | Trusopt |
| Dorzolamide with Timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | 1 | 5 | Cosopt |
| Dothiepin [NP] | Capsule containing dothiepin hydrochloride 25 mg | Oral | 50 | 2 | Dothep 25 |
| Prothiaden | |||||
| Tablet containing dothiepin hydrochloride 75 mg | Oral | 30 | 2 | Dothep 75 | |
| Prothiaden | |||||
| Doxepin [NP] | Tablet 50 mg (as hydrochloride) | Oral | 50 | 2 | Deptran 50 |
| Capsule 10 mg (as hydrochloride) | Oral | 50 | 2 | Deptran 10 | |
| Sinequan | |||||
| Capsule 25 mg (as hydrochloride) | Oral | 50 | 2 | Deptran 25 | |
| Sinequan | |||||
| Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 10 mg in 5 mL single dose vial | Injection/intravesical | 4 | .. | Adriamycin Solution |
| Doxorubicin Ebewe | |||||
| Hospira Pty Limited | |||||
| Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 20 mg in 10 mL single dose vial | Injection/intravesical | 4 | .. | Adriamycin Solution | |
| Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 50 mg in 25 mL single dose vial | Injection/intravesical | 3 | .. | Adriamycin Solution | |
| Doxorubicin Ebewe | |||||
| Hospira Pty Limited | |||||
| Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 100 mg in 50 mL single dose vial | Injection/intravesical | 1 | .. | Doxorubicin Ebewe | |
| Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 200 mg in 100 mL single dose vial | Injection/intravesical | 1 | .. | Adriamycin | |
| Doxorubicin Ebewe | |||||
| Doxorubicin - Pegylated Liposomal | Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 20 mg in 10 mL | Injection | 1 | .. | Caelyx |
| Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 50 mg in 25 mL | Injection | 1 | .. | Caelyx | |
| Doxycycline [NP] | Tablet 100 mg (as monohydrate) | Oral | 7 | 1 | Chem mart Doxycycline |
| Doxyhexal | |||||
| GenRx Doxycycline | |||||
| Terry White Chemists Doxycycline | |||||
| Tablet 100 mg (as hydrochloride) | Oral | 7 | 1 | Doxsig | |
| Doxy-100 | |||||
| Doxylin 100 | |||||
| Vibramycin | |||||
| Capsule 100 mg (as hydrochloride) (containing enteric coated pellets) | Oral | 7 | 1 | Doryx | |
| Mayne Pharma Doxycycline | |||||
| Tablet 50 mg (as monohydrate) | Oral | 25 | 5 | Chem mart Doxycycline | |
| Doxyhexal | |||||
| Frakas | |||||
| GenRx Doxycycline | |||||
| Terry White Chemists Doxycycline | |||||
| Tablet 50 mg (as hydrochloride) | Oral | 25 | 5 | Doxy-50 | |
| Doxylin 50 | |||||
| Vibra-Tabs | |||||
| Capsule 50 mg (as hydrochloride) (containing enteric coated pellets) | Oral | 25 | 5 | Doryx | |
| Mayne Pharma Doxycycline | |||||
| Drotrecogin Alfa (activated) | Powder for I.V. infusion 5 mg | Injection | 1 | .. | Xigris |
| Duloxetine [NP] | Capsule 30 mg (as hydrochloride) | Oral | 28 | .. | Cymbalta |
| Capsule 60 mg (as hydrochloride) | Oral | 28 | 5 | Cymbalta | |
| Dydrogesterone [NP] | Tablet 10 mg | Oral | 28 | 2 | Duphaston |
| Eformoterol [NP] | Capsule containing powder for oral inhalation containing eformoterol fumarate dihydrate 12 micrograms (for use in Foradile Aerolizer) | Inhalation by mouth | 60 | 5 | Foradile |
| Powder for oral inhalation in breath actuated device containing eformoterol fumarate dihydrate 6 micrograms per dose, 60 doses | Inhalation by mouth | 1 | 5 | Oxis Turbuhaler | |
| Powder for oral inhalation in breath actuated device containing eformoterol fumarate dihydrate 12 micrograms per dose, 60 doses | Inhalation by mouth | 1 | 5 | Oxis Turbuhaler | |
| Electrolyte Replacement, Oral [NP] | Oral rehydration salts containing glucose 3.56 g, sodium chloride 470 mg, potassium chloride 300 mg and sodium acid citrate 530 mg per sachet, 10 | Oral | 1 | .. | O.R.S. |
| Repalyte New Formulation | |||||
| restore O.R.S. | |||||
| Electrolyte Replacement, Solution [NP] | Electrolyte replacement solution containing sodium chloride 5.26 g, sodium acetate 3.68 g, sodium gluconate 5.02 g, potassium chloride 370 mg and magnesium chloride 300 mg per L, 1 L | Injection | 2 | 1 | Plasma-Lyte 148 |
| Eletriptan [NP] | Tablet 40 mg (as hydrobromide) | Oral | 4 | 5 | Relpax |
| Tablet 80 mg (as hydrobromide) | Oral | 4 | 5 | Relpax | |
| Enalapril [NP] | Tablet containing enalapril maleate 5 mg | Oral | 30 | 5 | Alphapril |
| Auspril | |||||
| Chem mart Enalapril | |||||
| Enahexal | |||||
| Enalabell | |||||
| Enalapril-DP 5mg | |||||
| Enalapril generichealth | |||||
| Enalapril Sandoz | |||||
| Enalapril Winthrop | |||||
| GenRx Enalapril | |||||
| Renitec M | |||||
| Terry White Chemists Enalapril | |||||
| Tablet containing enalapril maleate 10 mg | Oral | 30 | 5 | Alphapril | |
| Auspril | |||||
| Chem mart Enalapril | |||||
| Enahexal | |||||
| Enalabell | |||||
| Enalapril-DP 10mg | |||||
| Enalapril-GA | |||||
| Enalapril generichealth | |||||
| Enalapril Sandoz | |||||
| Enalapril Winthrop | |||||
| GenRx Enalapril | |||||
| Renitec | |||||
| Terry White Chemists Enalapril | |||||
| Tablet containing enalapril maleate 20 mg | Oral | 30 | 5 | Alphapril | |
| Auspril | |||||
| Chem mart Enalapril | |||||
| Enahexal | |||||
| Enalabell | |||||
| Enalapril-DP 20mg | |||||
| Enalapril-GA | |||||
| Enalapril generichealth | |||||
| Enalapril Sandoz | |||||
| GenRx Enalapril | |||||
| Renitec 20 | |||||
| Terry White Chemists Enalapril | |||||
| Enalapril with Hydrochlorothiazide [NP] | Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg | Oral | 30 | 5 | Enalapril/HCT Sandoz |
| Renitec Plus 20/6 | |||||
| Enoxaparin [NP] | Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe | Injection | 20 | .. | Clexane |
| Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe | Injection | 20 | .. | Clexane | |
| Solution for injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL | Injection | 20 | .. | Clexane | |
| Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe | Injection | 10 | 1 | Clexane | |
| Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | 10 | 1 | Clexane | |
| Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | 10 | 1 | Clexane | |
| Entacapone [NP] | Tablet 200 mg | Oral | 200 | 4 | Comtan |
| Epirubicin | Solution for injection containing epirubicin hydrochloride 10 mg in 5 mL | Injection/intravesical | 4 | .. | Epirubicin Ebewe |
| Pharmorubicin Solution | |||||
| Solution for injection containing epirubicin hydrochloride 20 mg in 10 mL | Injection/intravesical | 4 | .. | Pharmorubicin Solution | |
| Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL | Injection/intravesical | 4 | .. | Epirubicin Ebewe | |
| Hospira Pty Limited | |||||
| Pharmorubicin Solution | |||||
| Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL | Injection/intravesical | 2 | .. | Epirubicin Ebewe | |
| Hospira Pty Limited | |||||
| Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL | Injection/intravesical | 1 | .. | Epirubicin Ebewe | |
| Eplerenone [NP] | Tablet 25 mg | Oral | 30 | 5 | Inspra |
| Tablet 50 mg | Oral | 30 | 5 | Inspra | |
| Eprosartan [NP] | Tablet 400 mg (as mesylate) | Oral | 56 | 5 | Teveten |
| Tablet 600 mg (as mesylate) | Oral | 28 | 5 | Teveten | |
| Eprosartan with Hydrochlorothiazide [NP] | Tablet 600 mg eprosartan (as mesylate) with 12.5 mg hydrochlorothiazide | Oral | 28 | 5 | Teveten Plus 600/12.5 |
| Eptifibatide | Solution for I.V. injection 20 mg (as acetate) in 10 mL | Injection | 2 | .. | Integrilin |
| Solution for I.V. infusion 75 mg (as acetate) in 100 mL | Injection | 3 | .. | Integrilin | |
| Erlotinib | Tablet 25 mg (as hydrochloride) | Oral | 30 | 3 | Tarceva |
| Tablet 100 mg (as hydrochloride) | Oral | 30 | 3 | Tarceva | |
| Tablet 150 mg (as hydrochloride) | Oral | 30 | 3 | Tarceva | |
| Erythromycin [NP] | Tablet 400 mg (as ethyl succinate) | Oral | 25 | 1 | E.E.S. 400 Filmtab |
| E-Mycin | |||||
| Capsule 250 mg (containing enteric coated pellets) | Oral | 25 | 1 | Eryc | |
| Mayne Pharma Erythromycin | |||||
| Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | 1 | 1 | E.E.S. 200 | |
| E-Mycin 200 | |||||
| Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | 1 | 1 | E.E.S. Granules | |
| E-Mycin 400 | |||||
| Powder for I.V. infusion 1 g (as lactobionate) | Injection | 5 | .. | Erythrocin-I.V. | |
| Escitalopram [NP] | Tablet 10 mg (as oxalate) | Oral | 28 | 5 | APO-Escitalopram |
| Chem mart Escitalopram | |||||
| Esipram | |||||
| Esitalo | |||||
| Lexam 10 | |||||
| Lexapro | |||||
| LoxaLate | |||||
| Terry White Chemists Escitalopram | |||||
| Tablet 20 mg (as oxalate) | Oral | 28 | 5 | APO-Escitalopram | |
| Chem mart Escitalopram | |||||
| Esipram | |||||
| Esitalo | |||||
| Lexam 20 | |||||
| Lexapro | |||||
| LoxaLate | |||||
| Terry White Chemists Escitalopram | |||||
| Oral solution 10 mg (as oxalate) per mL, 28 mL | Oral | 1 | 5 | Lexapro | |
| Esomeprazole [NP] | Tablet (enteric coated) 20 mg (as magnesium trihydrate) | Oral | 30 | 1 | Nexium |
| Tablet (enteric coated) 40 mg (as magnesium trihydrate) | Oral | 30 | 1 | Nexium | |
| Esomeprazole and Clarithromycin and Amoxycillin [NP] | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxycillin 500 mg (as trihydrate) | Oral | 1 | .. | Nexium Hp7 |
| Essential amino acids formula [NP] | Oral powder 200 g, 2 (Essential Amino Acid Mix) | Oral | 3 | 5 | Essential Amino Acid Mix |
| Essential amino acids formula with minerals and vitamin C [NP] | Oral powder 400 g (Dialamine) | Oral | 5 | 5 | Dialamine |
| Essential amino acids formula with vitamins and minerals [NP] | Sachets containing oral powder 12.5 g, 50 (EAA Supplement) | Oral | 4 | 5 | EAA Supplement |
| Etanercept | Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL | Injection | 2 | 3 | Enbrel |
| Injections 50 mg in 1 mL single use pre-filled syringes, 4 | Injection | 1 | 3 | Enbrel | |
| Injection 50 mg in 1 mL single use auto-injector, 4 | Injection | 1 | 3 | Enbrel | |
| Ethacrynic Acid [NP] | Tablet 25 mg | Oral | 200 | 1 | Edecrin |
| Ethosuximide [NP] | Capsule 250 mg | Oral | 200 | 2 | Zarontin |
| Oral solution 250 mg per 5 mL, 200 mL | Oral | 1 | 5 | Zarontin | |
| Etidronic Acid [NP] | Tablet containing disodium etidronate 200 mg | Oral | 60 | 5 | Didronel |
| Etidronic Acid and Calcium [NP] | Pack containing 28 tablets disodium etidronate 200 mg and 76 tablets calcium 500 mg (as carbonate) | Oral | 1 | 1 | Didrocal |
| Etonogestrel [NP] | Subcutaneous implant 68 mg | Implantation | 1 | .. | Implanon |
| Etoposide | Capsule 50 mg | Oral | 20 | .. | Vepesid |
| Capsule 100 mg | Oral | 10 | .. | Vepesid | |
| Solution for I.V. infusion 100 mg in 5 mL vial | Injection | 5 | .. | Etoposide Ebewe | |
| Hospira Pty Limited | |||||
| Powder for I.V. infusion 100 mg (as phosphate) | Injection | 5 | .. | Etopophos | |
| Powder for I.V. infusion 1 g (as phosphate) | Injection | 1 | .. | Etopophos | |
| Everolimus | Tablet 0.25 mg | Oral | 60 | 3 | Certican |
| Tablet 0.5 mg | Oral | 60 | 3 | Certican | |
| Tablet 0.75 mg | Oral | 120 | 3 | Certican | |
| Tablet 1 mg | Oral | 120 | 3 | Certican | |
| Exemestane [NP] | Tablet 25 mg | Oral | 30 | 5 | Aromasin |
| Exenatide [NP] | Injection solution 5 micrograms per dose in pre-filled pen, 60 doses | Injection | 1 | 5 | Byetta 5 microgram |
| Injection solution 10 micrograms per dose in pre-filled pen, 60 doses | Injection | 1 | 5 | Byetta 10 microgram | |
| Ezetimibe [NP] | Tablet 10 mg | Oral | 30 | 5 | Ezetrol |
| Ezetimibe with Simvastatin [NP] | Tablet 10 mg-10 mg | Oral | 30 | 5 | Vytorin |
| Tablet 10 mg-20 mg | Oral | 30 | 5 | Vytorin | |
| Tablet 10 mg-40 mg | Oral | 30 | 5 | Vytorin | |
| Tablet 10 mg-80 mg | Oral | 30 | 5 | Vytorin | |
| Famciclovir [NP] | Tablet 125 mg | Oral | 40 | 1 | APO-Famciclovir |
| Ezovir | |||||
| Famvir | |||||
| Favic 125 | |||||
| Tablet 250 mg | Oral | 20 | 1 | APO-Famciclovir | |
| Ezovir | |||||
| Famciclovir Sandoz | |||||
| Famvir | |||||
| Favic 250 | |||||
| Tablet 500 mg | Oral | 30 | .. | Famvir | |
| Favic 500 | |||||
| Famotidine [NP] | Tablet 20 mg | Oral | 60 | 5 | Ausfam 20 |
| Chem mart Famotidine | |||||
| Famohexal | |||||
| Famotidine Sandoz | |||||
| GenRx Famotidine | |||||
| Pamacid 20 | |||||
| Pepcidine M | |||||
| Pepzan | |||||
| Terry White Chemists Famotidine | |||||
| Tablet 40 mg | Oral | 30 | 5 | Ausfam 40 | |
| Chem mart Famotidine | |||||
| Famotidine Sandoz | |||||
| GenRx Famotidine | |||||
| Pamacid 40 | |||||
| Pepcidine | |||||
| Pepzan | |||||
| Terry White Chemists Famotidine | |||||
| Felodipine [NP] | Tablet 2.5 mg (extended release) | Oral | 30 | 5 | Felodur ER 2.5 mg |
| Plendil ER | |||||
| Tablet 5 mg (extended release) | Oral | 30 | 5 | Felodil XR 5 | |
| Felodur ER 5 mg | |||||
| Plendil ER | |||||
| Tablet 10 mg (extended release) | Oral | 30 | 5 | Felodil XR 10 | |
| Felodur ER 10 mg | |||||
| Plendil ER | |||||
| Fenofibrate [NP] | Tablet 48 mg | Oral | 60 | 5 | Lipidil |
| Tablet 145 mg | Oral | 30 | 5 | Lipidil | |
| Fentanyl [NP] | Transdermal patch 2.1 mg | Transdermal | 5 | .. |
| Transdermal patch 4.2 mg | Transdermal | 5 | .. | Durogesic 25 | |
| Transdermal patch 8.4 mg | Transdermal | 5 | .. | Durogesic 50 | |
| Transdermal patch 12.6 mg | Transdermal | 5 | .. | Durogesic 75 | |
| Transdermal patch 16.8 mg | Transdermal | 5 | .. | Durogesic 100 | |
| Ferrous Fumarate with Folic Acid [NP] | Tablet 310 mg (equivalent to 100 mg iron)-350 micrograms | Oral | 60 | 1 | Ferro-f-tab |
| Ferrous Sulfate [NP] | Oral liquid 30 mg per mL, 250 mL | Oral | 1 | 2 | Ferro-Liquid |
| Flecainide [NP] | Tablet containing flecainide acetate 50 mg | Oral | 60 | 5 | Tambocor |
| Tablet containing flecainide acetate 100 mg | Oral | 60 | 5 | Flecatab | |
| Tambocor | |||||
| Flucloxacillin [NP] [MW] | Capsule 250 mg (as sodium) [MW] | Oral | 24 | .. | Flopen |
| Staphylex 250 | |||||
| Capsule 500 mg (as sodium) [MW] | Oral | 24 | .. | Flopen | |
| Staphylex 500 | |||||
| Powder for oral liquid 125 mg (as sodium) per 5 mL, 100 mL | Oral | 1 | .. | Aspen Pharmacare Australia Pty Limited | |
| Powder for oral liquid 250 mg (as sodium) per 5 mL, 100 mL | Oral | 1 | .. | Aspen Pharmacare Australia Pty Limited | |
| Powder for injection 500 mg (as sodium) | Injection | 5 | .. | Flubiclox | |
| Flucil | |||||
| Powder for injection 1 g (as sodium) | Injection | 5 | 1 | Flubiclox | |
| Flucil | |||||
| Hospira Pty Limited | |||||
| Fluconazole [NP] | Capsule 50 mg | Oral | 28 | 5 | DBL Fluconazole |
| Diflucan | |||||
| Dizole 50 | |||||
| Fluconazole Sandoz | |||||
| Fluzole 50 | |||||
| Ozole | |||||
| Capsule 100 mg | Oral | 28 | 5 | DBL Fluconazole | |
| Diflucan | |||||
| Dizole 100 | |||||
| Fluconazole Sandoz | |||||
| Fluconazole Winthrop | |||||
| Ozole | |||||
| Capsule 200 mg | Oral | 28 | 5 | APO-Fluconazole | |
| DBL Fluconazole | |||||
| Diflucan | |||||
| Dizole 200 | |||||
| Fluconazole Sandoz | |||||
| Fluconazole Winthrop | |||||
| Fluzole 200 | |||||
| Ozole | |||||
| Solution for I.V. infusion 100 mg in 50 mL | Injection | 7 | .. | Diflucan | |
| Fluconazole-Claris | |||||
| Fluconazole Hexal | |||||
| Solution for I.V. infusion 200 mg in 100 mL | Injection | 7 | .. | Baxter Healthcare Pty Ltd | |
| Diflucan | |||||
| Fluconazole-Claris | |||||
| Fluconazole Hexal | |||||
| Fluconazole Sandoz | |||||
| Solution for I.V. infusion 400 mg in 200 mL | Injection | 1 | .. | Baxter Healthcare Pty Ltd | |
| Fludarabine | Tablet containing fludarabine phosphate 10 mg | Oral | 20 | 5 | Fludara |
| Powder for I.V. injection containing fludarabine phosphate 50 mg | Injection | 5 | 3 | Farine | |
| Fludara | |||||
| Fludarabine Actavis | |||||
| Solution for I.V. injection 50 mg fludarabine phosphate in 2 mL | Injection | 5 | 3 | Fludarabine Ebewe | |
| Fludrocortisone [NP] | Tablet containing fludrocortisone acetate 100 micrograms | Oral | 200 | 1 | Florinef |
| Fluorometholone [NP] | Eye drops 1 mg per mL, 5 mL | Application to the eye | 1 | 5 | Flucon |
| FML Liquifilm | |||||
| Eye drops containing fluorometholone acetate 1 mg per mL, 5 mL | Application to the eye | 1 | 2 | Flarex | |
| Fluorouracil | Injection 500 mg in 10 mL | Injection | 10 | .. | Fluorouracil Ebewe |
| Hospira Pty Limited | |||||
| Injection 1000 mg in 20 mL | Injection | 5 | .. | Fluorouracil Ebewe | |
| Fluoxetine [NP] | Tablet, dispersible, 20 mg (as hydrochloride) | Oral | 28 | 5 | Lovan 20 Tab |
| Prozac Tab | |||||
| Capsule 20 mg (as hydrochloride) | Oral | 28 | 5 | Auscap | |
| Chem mart Fluoxetine | |||||
| Fluohexal | |||||
| Fluoxebell | |||||
| Fluoxetine 20 | |||||
| Fluoxetine-GA | |||||
| Fluoxetine generichealth | |||||
| GenRx Fluoxetine | |||||
| Lovan | |||||
| Prozac 20 | |||||
| Terry White Chemists Fluoxetine | |||||
| Zactin | |||||
| Flupenthixol Decanoate [NP] | Oily I.M. injection 20 mg in 1 mL ampoule | Injection | 5 | .. | Fluanxol Depot |
| Oily I.M. injection 40 mg in 2 mL ampoule | Injection | 5 | .. | Fluanxol Depot | |
| Oily I.M. injection 100 mg in 1 mL ampoule | Injection | 5 | .. | Fluanxol Concentrated Depot | |
| Fluphenazine Decanoate [NP] | Injection 12.5 mg in 0.5 mL ampoule | Injection | 5 | .. | Modecate |
| Injection 25 mg in 1 mL ampoule | Injection | 5 | .. | Modecate | |
| Injection 50 mg in 2 mL ampoule | Injection | 5 | .. | Modecate | |
| Flurbiprofen [NP] | Eye drops containing flurbiprofen sodium 300 micrograms per mL, single dose units 0.4 mL, 5 | Application to the eye | 1 | .. | Ocufen |
| Flutamide [NP] | Tablet 250 mg | Oral | 100 | 5 | Eulexin |
| Flutamin | |||||
| Fluticasone [NP] | Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | 1 | 5 | Flixotide Junior |
| Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | 1 | 5 | Flixotide | |
| Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | 1 | 1 | Flixotide | |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses | Inhalation by mouth | 1 | 5 | Flixotide Junior Accuhaler | |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses | Inhalation by mouth | 1 | 5 | Flixotide Accuhaler | |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms per dose, 60 doses | Inhalation by mouth | 1 | 1 | Flixotide Accuhaler | |
| Fluticasone with Salmeterol [NP] | Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | 1 | 5 | Seretide MDI 50/25 |
| Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | 1 | 5 | Seretide MDI 125/25 | |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | 1 | 5 | Seretide Accuhaler 100/50 | |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | 1 | 5 | Seretide Accuhaler 250/50 | |
| Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | 1 | 5 | Seretide MDI 250/25 | |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | 1 | 5 | Seretide Accuhaler 500/50 | |
| Fluvastatin [NP] | Capsule 20 mg (as sodium) | Oral | 28 | 5 | Lescol |
| Vastin | |||||
| Capsule 40 mg (as sodium) | Oral | 28 | 5 | Lescol | |
| Vastin | |||||
| Tablet (prolonged release) 80 mg (as sodium) | Oral | 28 | 5 | Lescol XL | |
| Fluvoxamine [NP] | Tablet containing fluvoxamine maleate 50 mg | Oral | 30 | 5 | APO-Fluvoxamine |
| Faverin 50 | |||||
| Luvox | |||||
| Movox 50 | |||||
| Voxam | |||||
| Tablet containing fluvoxamine maleate 100 mg | Oral | 30 | 5 | APO-Fluvoxamine | |
| Faverin 100 | |||||
| Luvox | |||||
| Movox 100 | |||||
| Voxam | |||||
| Folic Acid [NP] | Tablet 500 micrograms | Oral | 200 | .. | Megafol 0.5 |
| Tablet 5 mg | Oral | 200 | 1 | Megafol 5 | |
| Folinic acid [NP] | Tablet containing calcium folinate equivalent to 15 mg folinic acid | Oral | 10 | .. | Leucovorin Calcium (Hospira Pty Limited) |
| Injection containing calcium folinate equivalent to 50 mg folinic acid in 5 mL | Injection | 5 | 5 | Calcium Folinate Ebewe | |
| Leucovorin Calcium (Hospira Pty Limited) | |||||
| Leucovorin Calcium (Hospira Pty Limited) | |||||
| Injection containing calcium folinate equivalent to 100 mg folinic acid in 10 mL | Injection | 10 | 1 | Calcium Folinate Ebewe | |
| Leucovorin Calcium (Hospira Pty Limited) | |||||
| Injection containing calcium folinate equivalent to 300 mg folinic acid in 30 mL | Injection | 4 | 1 | Leucovorin Calcium (Hospira Pty Limited) | |
| Follitropin Alfa | Injection 300 I.U. in 0.5 mL multi-dose cartridge | Injection | 3 | 5 | Gonal-f Pen |
| Injection 450 I.U. in 0.75 mL multi-dose cartridge | Injection | 3 | 5 | Gonal-f Pen | |
| Injection 900 I.U. in 1.5 mL multi-dose cartridge | Injection | 2 | 5 | Gonal-f Pen | |
| Follitropin Beta | Solution for injection 300 I.U. in 0.36 mL multi-dose cartridge | Injection | 3 | 5 | Puregon 300 IU/0.36 mL |
| Solution for injection 600 I.U. in 0.72 mL multi-dose cartridge | Injection | 2 | 5 | Puregon 600 IU/0.72 mL | |
| Solution for injection 900 I.U. in 1.08 mL multi-dose cartridge | Injection | 2 | 5 | Puregon 900 IU/1.08 mL | |
| Fondaparinux [NP] | Injection containing fondaparinux sodium 2.5 mg in 0.5 mL single dose pre-filled syringe | Injection | 7 | .. | Arixtra |
| Fosinopril [NP] | Tablet containing fosinopril sodium 10 mg | Oral | 30 | 5 | Fosinopril Sandoz |
| Fosipril 10 | |||||
| GenRx Fosinopril | |||||
| Monace 10 | |||||
| Monopril | |||||
| Tablet containing fosinopril sodium 20 mg | Oral | 30 | 5 | Fosinopril Sandoz | |
| Fosipril 20 | |||||
| GenRx Fosinopril | |||||
| Monace 20 | |||||
| Monopril | |||||
| Fosinopril with Hydrochlorothiazide [NP] | Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg | Oral | 30 | 5 | APO-Fosinopril HCTZ 10/12.5 |
| Fosinopril/HCT Sandoz 10mg/12.5mg | |||||
| Fosinopril/HCTZ-GA 10/12.5 | |||||
| Hyforil | |||||
| Monoplus 10/12.5 | |||||
| Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg | Oral | 30 | 5 | APO-Fosinopril HCTZ 20/12.5 | |
| Fosetic 20/12.5 | |||||
| Fosinopril/HCT Sandoz 20mg/12.5mg | |||||
| Fosinopril/HCTZ-GA 20/12.5 | |||||
| Hyforil | |||||
| Monoplus 20/12.5 | |||||
| Fotemustine | Powder for injection 208 mg with solvent | Injection | 1 | 4 | Muphoran |
| Framycetin [NP] [MW] | Eye or ear drops containing framycetin sulfate 5 mg per mL, 8 mL | Application to the eye/ear | 1 | 2 | Soframycin |
| Frusemide [NP] | Tablet 20 mg | Oral | 100 | 1 | Chem mart Frusemide |
| Frusid | |||||
| GenRx Frusemide | |||||
| Lasix-M | |||||
| Terry White Chemists Frusemide | |||||
| Urex-M | |||||
| Tablet 40 mg | Oral | 100 | 1 | Chem mart Frusemide | |
| Frusemide Sandoz | |||||
| Frusid | |||||
| GenRx Frusemide | |||||
| Lasix | |||||
| Terry White Chemists Frusemide | |||||
| Uremide | |||||
| Urex | |||||
| Tablet 500 mg | Oral | 50 | 3 | Urex-Forte | |
| Oral solution 10 mg per mL, 30 mL | Oral | 1 | 3 | Lasix | |
| Injection 20 mg in 2 mL | Injection | 5 | .. | Frusehexal | |
| Frusemide-Claris | |||||
| Lasix | |||||
| Fusidic Acid | Tablet containing sodium fusidate 250 mg | Oral | 36 | 1 | Fucidin |
| Gabapentin [NP] | Capsule 100 mg | Oral | 100 | 5 | APO-Gabapentin |
| DBL Gabapentin | |||||
| Gabatine 100 | |||||
| Gantin | |||||
| Neurontin | |||||
| Nupentin 100 | |||||
| Capsule 300 mg | Oral | 100 | 5 | DBL Gabapentin | |
| Gabapentin 300 | |||||
| Gabapentin-GA | |||||
| Gabapentin Sandoz | |||||
| Gabatine 300 | |||||
| Gantin | |||||
| GenRx Gabapentin | |||||
| Neurontin | |||||
| Nupentin 300 | |||||
| Capsule 400 mg | Oral | 100 | 5 | DBL Gabapentin | |
| Douglas Gabapentin 400mg | |||||
| Gabapentin 400 | |||||
| Gabapentin Sandoz | |||||
| Gabatine 400 | |||||
| Gantin | |||||
| GenRx Gabapentin | |||||
| Neurontin | |||||
| Nupentin 400 | |||||
| Tablet 600 mg | Oral | 100 | 5 | Gabahexal 600mg | |
| Gabaran | |||||
| Gabatine 600 | |||||
| GenRx Gabapentin | |||||
| Neurontin | |||||
| Tablet 800 mg | Oral | 100 | 5 | Gabaran | |
| Gabatine 800 | |||||
| Gantin | |||||
| GenRx Gabapentin | |||||
| Neurontin | |||||
| Pendine 800 | |||||
| Galantamine [NP] | Capsule (prolonged release) 8 mg (as hydrobromide) | Oral | 28 | 5 | Galantyl |
| Reminyl | |||||
| Capsule (prolonged release) 16 mg (as hydrobromide) | Oral | 28 | 5 | Galantyl | |
| Reminyl | |||||
| Capsule (prolonged release) 24 mg (as hydrobromide) | Oral | 28 | 5 | Galantyl | |
| Reminyl | |||||
| Gefitinib | Tablet 250 mg | Oral | 30 | 1 | Iressa |
| Gelatin - Succinylated [NP] | I.V. infusion 20 g per 500 mL, 500 mL | Injection | 3 | .. | Gelofusine |
| Gemcitabine | Powder for I.V. infusion 200 mg (as hydrochloride) | Injection | 4 | 2 | DBL Gemcitabine for Injection |
| Gemcitabine Actavis | |||||
| Gemcitabine Ebewe | |||||
| Gemcite | |||||
| Gemzar | |||||
| Solution concentrate for I.V. infusion 200 mg (as hydrochloride) in 20 mL | Injection | 4 | 2 | Gemcitabine Ebewe | |
| Solution concentrate for I.V. infusion 500 mg (as hydrochloride) in 50 mL | Injection | 4 | 2 | Gemcitabine Ebewe | |
| Powder for I.V. infusion 1 g (as hydrochloride) | Injection | 2 | 2 | DBL Gemcitabine for Injection | |
| Gemcitabine Actavis | |||||
| Gemcitabine Ebewe | |||||
| Gemcite | |||||
| Gemzar | |||||
| Solution concentrate for I.V. infusion 1000 mg (as hydrochloride) in 100 mL | Injection | 2 | 2 | Gemcitabine Ebewe | |
| Powder for I.V. infusion 2 g (as hydrochloride) | Injection | 1 | 2 | DBL Gemcitabine for Injection | |
| Gemfibrozil [NP] | Tablet 600 mg | Oral | 60 | 5 | Ausgem |
| Chem mart Gemfibrozil | |||||
| Gemhexal | |||||
| GenRx Gemfibrozil | |||||
| Jezil | |||||
| Lipazil 600 mg | |||||
| Lipigem | |||||
| Lopid | |||||
| Pharmacor Gemfibrozil 600 | |||||
| Terry White Chemists Gemfibrozil | |||||
| Gentamicin [NP] | Injection 80 mg (as sulfate) in 2 mL [NP] | Injection | 10 | 1 | Hospira Pty Limited |
| Pfizer Australia Pty Ltd | |||||
| Eye drops 3 mg (as sulfate) per mL, 5 mL | Application to the eye | 1 | 2 | Genoptic | |
| Gestrinone | Capsule 2.5 mg | Oral | 8 | 5 | Dimetriose |
| Glatiramer | Injection containing glatiramer acetate 20 mg in 1 mL single dose pre-filled syringe | Injection | 28 | 5 | Copaxone |
| Glibenclamide [NP] | Tablet 5 mg | Oral | 100 | 5 | Daonil |
| Glimel | |||||
| Gliclazide [NP] | Tablet 30 mg (modified release) | Oral | 100 | 5 | APO-Gliclazide MR |
| Chem mart Gliclazide MR | |||||
| Glyade MR | |||||
| Oziclide MR | |||||
| Terry White Chemists Gliclazide MR | |||||
| Tablet 60 mg (modified release) | Oral | 60 | 5 | Diamicron 60mg MR | |
| Tablet 80 mg | Oral | 100 | 5 | Chem mart Gliclazide | |
| GenRx Gliclazide | |||||
| Glyade | |||||
| Mellihexal | |||||
| Nidem | |||||
| Terry White Chemists Gliclazide | |||||
| Glimepiride [NP] | Tablet 1 mg | Oral | 30 | 5 | Amaryl |
| APO-Glimepiride | |||||
| Aylide 1 | |||||
| Diapride 1 | |||||
| Dimirel | |||||
| Glimepiride Sandoz | |||||
| Tablet 2 mg | Oral | 30 | 5 | Amaryl | |
| APO-Glimepiride | |||||
| Aylide 2 | |||||
| Diapride 2 | |||||
| Dimirel | |||||
| Glimepiride Sandoz | |||||
| Tablet 3 mg | Oral | 30 | 5 | Amaryl | |
| APO-Glimepiride | |||||
| Aylide 3 | |||||
| Diapride 3 | |||||
| Dimirel | |||||
| Glimepiride Sandoz | |||||
| Tablet 4 mg | Oral | 30 | 5 | Amaryl | |
| APO-Glimepiride | |||||
| Aylide 4 | |||||
| Diapride 4 | |||||
| Dimirel | |||||
| Glimepiride Sandoz | |||||
| Glipizide [NP] | Tablet 5 mg | Oral | 100 | 5 | Melizide |
| Minidiab | |||||
| Glucagon [NP] | Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe | Injection | 1 | 1 | GlucaGen Hypokit |
| Glucose [NP] | I.V. infusion 69.5 mmol (anhydrous) per 250 mL, 250 mL | Injection | 5 | 1 | B. Braun Australia Pty Ltd |
| Glucose 5% Freeflex | |||||
| I.V. infusion 139 mmol (anhydrous) per 500 mL, 500 mL | Injection | 5 | 1 | B. Braun Australia Pty Ltd | |
| Fresenius Kabi Australia Pty Limited | |||||
| I.V. infusion 278 mmol (anhydrous) per 500 mL, 500 mL | Injection | 5 | 1 | Fresenius Kabi Australia Pty Limited | |
| I.V. infusion 278 mmol (anhydrous) per L, 1 L | Injection | 5 | 1 | B. Braun Australia Pty Ltd | |
| Baxter Healthcare Pty Ltd | |||||
| Fresenius Kabi Australia Pty Limited | |||||
| Glucose and Ketone Indicator—Urine [NP] | Test strips, 50 (Keto-Diabur-Test 5000) | For external use | 2 | 2 | Keto-Diabur- Test 5000 |
| Test strips, 50 (Keto-Diastix) | For external use | 2 | 2 | Keto-Diastix | |
| Glucose Indicator—Blood [NP] | Test strips, 25 (On-Call Plus) | For external use | 4 | 5 | On-Call Plus |
| Test strips, 50 (Accu-Chek Go) | For external use | 2 | 5 | Accu-Chek Go | |
| Test strips, 51 (Accu-Chek Integra) | For external use | 2 | 5 | Accu-Chek Integra | |
| Test strips, 50 (Advantage II) | For external use | 2 | 5 | Advantage II | |
| Test strips, 50 (Betachek) | For external use | 2 | 5 | Betachek | |
| Test strips, 50 (Betachek G5) | For external use | 2 | 5 | Betachek G5 | |
| Test strips, 50 (Bionime Rightest) | For external use | 2 | 5 | Bionime Rightest | |
| Test strips, 50 (CareSens) | For external use | 2 | 5 | CareSens | |
| Test strips, 50 (CareSens N) | For external use | 2 | 5 | CareSens N | |
| Test strips, 50 (Freestyle Papillon) | For external use | 2 | 5 | Freestyle Papillon | |
| Test strips, 50 (Glucocard 01 Sensor) | For external use | 2 | 5 | Glucocard 01 Sensor | |
| Test strips, 50 (Glucoflex-R) | For external use | 2 | 5 | Glucoflex-R | |
| Test strips, 50 (GlucoOz) | For external use | 2 | 5 | GlucoOz | |
| Test strips, 50 (Glucostix) | For external use | 2 | 5 | Glucostix | |
| Test strips, 50 (Lifeline Attest) | For external use | 2 | 5 | Lifeline Attest | |
| Test strips, 50 (MWD Pen Sensor Strips) | For external use | 2 | 5 | MWD Pen Sensor Strips | |
| Test strips, 50 (MyGlucoHealth) | For external use | 2 | 5 | MyGlucoHealth | |
| Test strips, 50 (Omnitest EZ) | For external use | 2 | 5 | Omnitest EZ | |
| Test strips, 50 (OneTouch Verio) | For external use | 2 | 5 | OneTouch Verio | |
| Test strips, 50 (Optium Omega) | For external use | 2 | 5 | Optium Omega | |
| Test strips, 50 (SensoCard) | For external use | 2 | 5 | SensoCard | |
| Test strips, 50 (TrueTrack) | For external use | 2 | 5 | TrueTrack | |
| Test strips, 50 (WaveSense Jazz) | For external use | 2 | 5 | WaveSense Jazz | |
| Test strips, 100 (Accu-Chek Active) | For external use | 1 | 5 | Accu-Chek Active | |
| Test strips, 100 (Accu-Chek Advantage/Sensor Comfort) | For external use | 1 | 5 | Accu-Chek Advantage/Sensor Comfort | |
| Test strips, 100 (Accu-Chek Mobile) | For external use | 1 | 5 | Accu-Chek Mobile | |
| Test strips, 100 (Accu-Chek Performa) | For external use | 1 | 5 | Accu-Chek Performa | |
| Test strips, 100 (FreeStyle Lite) | For external use | 1 | 5 | FreeStyle Lite | |
| Test strips, 100 (Optium glucose) | For external use | 1 | 5 | Optium glucose | |
| Glucose Indicator—Urine [NP] | Test strips, 50 (Clinistix) | For external use | 2 | 2 | Clinistix |
| Test strips, 50 (Diastix) | For external use | 2 | 2 | Diastix | |
| Glycerol [NP] | Suppositories 700 mg, 12 | Rectal | 3 | 5 | Petrus Pharmaceuticals Pty Ltd |
| Suppositories 1.4 g, 12 | Rectal | 3 | 5 | Petrus Pharmaceuticals Pty Ltd | |
| Suppositories 2.8 g, 12 | Rectal | 3 | 5 | Petrus Pharmaceuticals Pty Ltd | |
| Glyceryl Trinitrate [NP] | Tablets 600 micrograms, 100 | Buccal/sublingual | 1 | 5 | Anginine Stabilised |
| Lycinate | |||||
| Sublingual spray (pump pack) 400 micrograms per dose, 200 doses | Sublingual | 1 | 5 | Nitrolingual Pumpspray | |
| Transdermal patch 18 mg | Transdermal | 30 | 5 | Minitran 5 | |
| Transdermal patch 25 mg | Transdermal | 30 | 5 | Transiderm-Nitro 25 | |
| Transdermal patch 40 mg | Transdermal | 30 | 5 | Nitro-Dur 5 | |
| Transdermal patch 36 mg | Transdermal | 30 | 5 | Minitran 10 | |
| Transdermal patch 50 mg | Transdermal | 30 | 5 | Transiderm-Nitro 50 | |
| Transdermal patch 80 mg | Transdermal | 30 | 5 | Nitro-Dur 10 | |
| Transdermal patch 54 mg | Transdermal | 30 | 5 | Minitran 15 | |
| Transdermal patch 120 mg | Transdermal | 30 | 5 | Nitro-Dur 15 | |
| Golimumab | Injection 50 mg in 0.5 mL single use pre-filled syringe | Injection | 1 | 3 | Simponi |
| Injection 50 mg in 0.5 mL single use pre-filled pen | Injection | 1 | 3 | Simponi | |
| Goserelin | Subcutaneous implant 3.6 mg (as acetate) in pre-filled injection syringe | Implantation | 1 | 5 | Zoladex Implant |
| Subcutaneous implant (long acting) 10.8 mg (as acetate) in pre-filled injection syringe | Implantation | 1 | 1 | Zoladex 10.8 Implant | |
| Goserelin and Bicalutamide | Pack containing 1 subcutaneous implant containing goserelin 3.6 mg (as acetate) in pre-filled injection syringe and 28 tablets bicalutamide 50 mg | Implantation/oral | 1 | 5 | ZolaCos CP 3.6/50 |
| Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre-filled injection syringe and 28 tablets bicalutamide 50 mg | Implantation/oral | 1 | .. | ZolaCos CP 10.8/50(28) | |
| Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre-filled injection syringe and 84 tablets bicalutamide 50 mg | Implantation/oral | 1 | 1 | ZolaCos CP 10.8/50(84) | |
| Granisetron [NP] | Tablet 2 mg (as hydrochloride) | Oral | 2 | .. | Kytril |
| Concentrated injection 3 mg (as hydrochloride) in 3 mL | Injection | 1 | .. | Kytril | |
| Griseofulvin [NP] | Tablet 125 mg | Oral | 100 | 2 | Grisovin |
| Tablet 500 mg | Oral | 28 | 2 | Grisovin 500 | |
| Haloperidol [NP] | Tablet 500 micrograms | Oral | 100 | 5 | Serenace |
| Tablet 1.5 mg | Oral | 100 | 5 | Serenace | |
| Tablet 5 mg | Oral | 50 | 5 | Serenace | |
| Oral solution 2 mg per mL, 100 mL | Oral | 1 | 5 | Serenace | |
| Injection 5 mg in 1 mL | Injection | 10 | .. | Serenace | |
| Haloperidol Decanoate [NP] | I.M. injection equivalent to 50 mg haloperidol in 1 mL ampoule | Injection | 5 | .. | Haldol decanoate |
| I.M. injection equivalent to 150 mg haloperidol in 3 mL ampoule | Injection | 5 | .. | Haldol decanoate | |
| Heparin [NP] | Injection 5,000 units (as sodium) in 0.2 mL | Injection | 5 | 5 | Hospira Pty Limited |
| Injection (preservative-free) 5,000 I.U. (as sodium) in 5 mL | Injection | 50 | 5 | Pfizer Australia Pty Ltd | |
| Injection 35,000 units (as sodium) in 35 mL | Injection | 12 | 5 | Hospira Pty Limited | |
| Hexamine [NP] | Tablet containing hexamine hippurate 1 g | Oral | 100 | 5 | Hiprex |
| High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate [NP] | Oral powder 300 g (KetoCal) | Oral | 24 | 5 | KetoCal |
| Homatropine [NP] | Eye drops containing homatropine hydrobromide 20 mg per mL, 15 mL | Application to the eye | 1 | 2 | Isopto Homatropine |
| Hydralazine [NP] | Tablet containing hydralazine hydrochloride 25 mg | Oral | 200 | 2 | Alphapress 25 |
| Tablet containing hydralazine hydrochloride 50 mg | Oral | 200 | 2 | Alphapress 50 | |
| Hydrochlorothiazide [NP] | Tablet 25 mg | Oral | 100 | 1 | Dithiazide |
| Hydrochlorothiazide with Amiloride [NP] | Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg | Oral | 100 | 1 | Moduretic |
| Hydrochlorothiazide with Triamterene [NP] | Tablet 25 mg-50 mg | Oral | 100 | 1 | Hydrene 25/50 |
| Hydrocortisone [NP] | Tablet 4 mg | Oral | 50 | 4 | Hysone 4 |
| Tablet 20 mg | Oral | 60 | 4 | Hysone 20 | |
| Injection 100 mg (as sodium succinate) with 2 mL solvent | Injection | 2 | .. | Solu-Cortef | |
| Injection 250 mg (as sodium succinate) with 2 mL solvent | Injection | 1 | .. | Solu-Cortef | |
| Eye ointment containing hydrocortisone acetate 5 mg per g, 5 g | Application to the eye | 1 | .. | Hycor | |
| Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g | Application to the eye | 1 | .. | Hycor | |
| Cream containing hydrocortisone acetate 10 mg per g, 30 g | Application | 1 | 1 | Cortic-DS 1% | |
| Sigmacort | |||||
| Cream containing hydrocortisone acetate 10 mg per g, 50 g | Application | 1 | 1 | Cortef | |
| Cortic-DS 1% | |||||
| Sigmacort | |||||
| Ointment containing hydrocortisone acetate 10 mg per g, 30 g | Application | 1 | 1 | Cortic-DS 1% | |
| Sigmacort | |||||
| Ointment containing hydrocortisone acetate 10 mg per g, 50 g | Application | 1 | 1 | Cortic-DS 1% | |
| Sigmacort | |||||
| Rectal foam containing hydrocortisone acetate 90 mg per applicatorful, 14 applications, aerosol 21.1 g | Rectal | 2 | 3 | Colifoam | |
| Hydromorphone [NP] | Tablet containing hydromorphone hydrochloride 2 mg | Oral | 20 | .. | Dilaudid |
| Tablet containing hydromorphone hydrochloride 4 mg | Oral | 20 | .. | Dilaudid | |
| Tablet containing hydromorphone hydrochloride 8 mg | Oral | 20 | .. | Dilaudid | |
| Tablet (modified release) containing hydromorphone hydrochloride 4 mg | Oral | 14 | .. | Jurnista | |
| Tablet (modified release) containing hydromorphone hydrochloride 8 mg | Oral | 14 | .. | Jurnista | |
| Tablet (modified release) containing hydromorphone hydrochloride 16 mg | Oral | 14 | .. | Jurnista | |
| Tablet (modified release) containing hydromorphone hydrochloride 32 mg | Oral | 14 | .. | Jurnista | |
| Tablet (modified release) containing hydromorphone hydrochloride 64 mg | Oral | 14 | .. | Jurnista | |
| Oral liquid containing hydromorphone hydrochloride 1 mg per mL, 473 mL | Oral | 1 | .. | Dilaudid | |
| Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | 5 | .. | Dilaudid | |
| Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | 5 | .. | Dilaudid-HP | |
| Injection containing hydromorphone hydrochloride 50 mg in 5 mL | Injection | 5 | .. | Dilaudid-HP | |
| Injection containing hydromorphone hydrochloride 500 mg in 50 mL | Injection | 1 | .. | Dilaudid-HP | |
| Hydroxocobalamin [NP] | Injection 1 mg in 1 mL | Injection | 3 | .. | Neo-B12 |
| Hydroxychloroquine [NP] | Tablet containing hydroxychloroquine sulfate 200 mg | Oral | 100 | 1 | Plaquenil |
| Hydroxyethyl starch 130/0.4 [NP] | I.V. infusion 30 g per 500 mL, 500 mL | Injection | 3 | .. | Voluven 6% |
| Hydroxyurea | Capsule 500 mg | Oral | 100 | .. | Hydrea |
| Hypromellose [NP] | Eye drops 3 mg per mL, 15 mL | Application to the eye | 1 | 5 | Genteal |
| In a Wink Moisturising | |||||
| Eye drops 5 mg per mL, 15 mL | Application to the eye | 1 | 5 | Methopt | |
| Hypromellose with Carbomer 980 [NP] | Ocular lubricating gel 3 mg-2 mg per g, 10 g | Application to the eye | 1 | 5 | Genteal gel |
| HPMC PAA | |||||
| Hypromellose with Dextran [NP] | Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL | Application to the eye | 1 | 5 | Poly-Tears |
| Tears Naturale | |||||
| Eye drops containing 3 mg hypromellose 2900 with 1 mg dextran 70 per mL, single dose units 0.4 mL, 28 | Application to the eye | 3 | 5 | Bion Tears | |
| Ibandronic acid [NP] | Tablet 50 mg (as ibandronate sodium monohydrate) | Oral | 28 | 2 | Bondronat |
| Ibuprofen [NP] [MW] | Tablet 400 mg | Oral | 30 | .. | Brufen |
| Idarubicin | Capsule containing idarubicin hydrochloride 5 mg | Oral | 3 | .. | Zavedos |
| Capsule containing idarubicin hydrochloride 10 mg | Oral | 3 | .. | Zavedos | |
| Solution for I.V. injection containing idarubicin hydrochloride 5 mg in 5 mL single use vial | Injection | 3 | .. | Zavedos Solution | |
| Solution for I.V. injection containing idarubicin hydrochloride 10 mg in 10 mL single use vial | Injection | 6 | .. | Zavedos Solution | |
| Ifosfamide | Powder for I.V. injection 1 g in single dose vial | Injection | 5 | 5 | Holoxan |
| Powder for I.V. injection 2 g in single dose vial | Injection | 5 | 5 | Holoxan | |
| Imatinib | Tablet 100 mg (as mesylate) | Oral | 60 | 2 | Glivec |
| Tablet 400 mg (as mesylate) | Oral | 30 | 2 | Glivec | |
| Imipramine [NP] | Tablet containing imipramine hydrochloride 10 mg | Oral | 50 | 2 | Tofranil 10 |
| Tolerade 10 | |||||
| Tablet containing imipramine hydrochloride 25 mg | Oral | 50 | 2 | Tofranil 25 | |
| Tolerade 25 | |||||
| Imiquimod | Cream 50 mg per g, 250 mg single use sachets, 12 | Application | 1 | 1 | Aldara |
| Indapamide [NP] | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | 90 | 1 | Natrilix SR |
| Tablet containing indapamide hemihydrate 2.5 mg | Oral | 90 | 1 | Chem mart Indapamide | |
| Dapa-Tabs | |||||
| GenRx Indapamide | |||||
| Indahexal | |||||
| Indapamide-GA | |||||
| Indapamide Sandoz | |||||
| Insig | |||||
| Natrilix | |||||
| Terry White Chemists Indapamide | |||||
| Indomethacin [NP] | Capsule 25 mg | Oral | 100 | 3 | Arthrexin |
| Indocid | |||||
| Suppository 100 mg | Rectal | 40 | 3 | Indocid | |
| Insect Allergen Extract—Honey Bee Venom | Injection set containing 550 micrograms | Injection | 1 | .. | Albey Bee Venom |
| Insect Allergen Extract—Paper Wasp Venom | Injection set containing 550 micrograms | Injection | 1 | .. | Albey Paper Wasp Venom |
| Insect Allergen Extract—Yellow Jacket Venom | Injection set containing 550 micrograms | Injection | 1 | .. | Albey Yellow Jacket Venom |
| Insulin Aspart [NP] | Injection (human analogue) 100 units per mL, 10 mL vial | Injection | 5 | 2 | NovoRapid |
| Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | 5 | 1 | NovoRapid FlexPen | |
| NovoRapid Penfill 3 mL | |||||
| Insulin Aspart with Insulin Aspart Protamine Suspension [NP] | Injections (human analogue), cartridges, 30 units-70 units per mL, 3 mL, 5 | Injection | 5 | 1 | NovoMix 30 FlexPen |
| NovoMix 30 Penfill 3 mL | |||||
| Insulin Detemir [NP] | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | 5 | 1 | Levemir FlexPen |
| Levemir Penfill | |||||
| Insulin Glargine [NP] | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | 5 | 1 | Lantus |
| Lantus SoloStar | |||||
| Insulin Glulisine [NP] | Injection (human analogue) 100 units per mL, 10 mL | Injection | 5 | 2 | Apidra |
| Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | 5 | 1 | Apidra | |
| Apidra SoloStar | |||||
| Insulin Isophane [NP] | Injection (bovine) 100 units per mL, 10 mL | Injection | 5 | 2 | Hypurin Isophane |
| Injection (human) 100 units per mL, 10 mL | Injection | 5 | 2 | Humulin NPH | |
| Protaphane | |||||
| Injections (human), cartridges, 100 units per mL, 3 mL, 5 | Injection | 5 | 1 | Humulin NPH | |
| Protaphane InnoLet | |||||
| Protaphane NovoLet 3 mL | |||||
| Protaphane Penfill 3 mL | |||||
| Insulin Lispro [NP] | Injection (human analogue) 100 units per mL, 10 mL vial | Injection | 5 | 2 | Humalog |
| Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | 5 | 1 | Humalog | |
| Humalog KwikPen | |||||
| Insulin Lispro with Insulin Lispro Protamine Suspension [NP] | Injections (human analogue), cartridges, 25 units-75 units per mL, 3 mL, 5 | Injection | 5 | 1 | Humalog Mix25 |
| Humalog Mix25 KwikPen | |||||
| Injections (human analogue), cartridges, 50 units-50 units per mL, 3 mL, 5 | Injection | 5 | 1 | Humalog Mix50 | |
| Humalog Mix50 KwikPen | |||||
| Insulin Neutral [NP] | Injection (bovine) 100 units per mL, 10 mL | Injection | 5 | 2 | Hypurin Neutral |
| Injection (human) 100 units per mL, 10 mL | Injection | 5 | 2 | Actrapid | |
| Humulin R | |||||
| Injections (human), cartridges, 100 units per mL, 3 mL, 5 | Injection | 5 | 1 | Actrapid Penfill 3 mL | |
| Humulin R | |||||
| Insulin Neutral with Insulin Isophane [NP] | Injection (human) 30 units-70 units per mL, 10 mL | Injection | 5 | 2 | Humulin 30/70 |
| Injections (human), cartridges, 30 units-70 units per mL, 3 mL, 5 | Injection | 5 | 1 | Humulin 30/70 | |
| Mixtard 30/70 InnoLet | |||||
| Mixtard 30/70 Penfill 3 mL | |||||
| Injections (human), cartridges, 50 units-50 units per mL, 3 mL, 5 | Injection | 5 | 1 | Mixtard 50/50 Penfill 3 mL | |
| Interferon Alfa-2a | Injection 3,000,000 I.U. in 0.5 mL single dose pre-filled syringe | Injection | 15 | 4 | Roferon-A |
| Injection 4,500,000 I.U. in 0.5 mL single dose pre-filled syringe | Injection | 5 | 4 | Roferon-A | |
| Injection 6,000,000 I.U. in 0.5 mL single dose pre-filled syringe | Injection | 5 | 4 | Roferon-A | |
| Injection 9,000,000 I.U. in 0.5 mL single dose pre-filled syringe | Injection | 5 | 4 | Roferon-A | |
| Interferon Alfa-2b | Solution for injection 18,000,000 I.U. in 1.2 mL multi-dose injection pen | Injection | 3 | 4 | Intron A Redipen |
| Solution for injection 30,000,000 I.U. in 1.2 mL multi-dose injection pen | Injection | 3 | 5 | Intron A Redipen | |
| Interferon Beta-1a | Injection set comprising 1 vial powder for injection 30 micrograms (6,000,000 I.U.) with diluent | Injection | 4 | 5 | Avonex |
| Injection 30 micrograms (6,000,000 I.U.) in 0.5 mL single dose pre-filled syringe | Injection | 4 | 5 | Avonex | |
| Injection 44 micrograms (12,000,000 I.U.) in 0.5 mL single dose pre-filled syringe | Injection | 12 | 5 | Rebif 44 | |
| Solution for injection 132 micrograms in 1.5 mL multidose cartridge | Injection | 4 | 5 | Rebif 44 | |
| Interferon Beta-1b | Injection set including 1 vial powder for injection 8,000,000 I.U. (250 micrograms) and solvent | Injection | 15 | 5 | Betaferon |
| Ipratropium [NP] | Pressurised inhalation containing ipratropium bromide 21 micrograms per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | 2 | 5 | Atrovent |
| Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous) in 1 mL single dose units, 30 | Inhalation | 2 | 5 | Aeron 250 | |
| APO-Ipratropium | |||||
| Atrovent | |||||
| Ipratrin | |||||
| Ipravent | |||||
| Nebuliser solution containing ipratropium bromide 500 micrograms (anhydrous) in 1 mL single dose units, 30 | Inhalation | 2 | 5 | Aeron 500 | |
| APO-Ipratropium | |||||
| Atrovent Adult | |||||
| Ipratrin Adult | |||||
| Ipravent | |||||
| Irbesartan [NP] | Tablet 75 mg | Oral | 30 | 5 | Avapro |
| Karvea | |||||
| Tablet 150 mg | Oral | 30 | 5 | Avapro | |
| Karvea | |||||
| Tablet 300 mg | Oral | 30 | 5 | Avapro | |
| Karvea | |||||
| Irbesartan with Hydrochlorothiazide [NP] | Tablet 150 mg-12.5 mg | Oral | 30 | 5 | Avapro HCT 150/12.5 |
| Karvezide 150/12.5 | |||||
| Tablet 300 mg-12.5 mg | Oral | 30 | 5 | Avapro HCT 300/12.5 | |
| Karvezide 300/12.5 | |||||
| Tablet 300 mg-25 mg | Oral | 30 | 5 | Avapro HCT 300/25 | |
| Karvezide 300/25 | |||||
| Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection | 1 | 3 | Camptosar |
| Hospira Pty Limited | |||||
| Irinotecan Actavis | |||||
| Irinotecan Alphapharm | |||||
| Irinotecan Ebewe | |||||
| Irinotecan Sandoz | |||||
| Omegapharm Irinotecan | |||||
| Tecan | |||||
| I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | 2 | 3 | Camptosar | |
| Hospira Pty Limited | |||||
| Irinotecan Actavis | |||||
| Irinotecan Alphapharm | |||||
| Irinotecan Ebewe | |||||
| Irinotecan Sandoz | |||||
| Omegapharm Irinotecan | |||||
| Tecan | |||||
| I.V. injection containing irinotecan hydrochloride trihydrate 300 mg in 15 mL | Injection | 1 | 3 | Camptosar | |
| Irinotecan Ebewe | |||||
| I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection | 1 | 3 | Hospira Pty Limited | |
| Irinotecan Ebewe | |||||
| Iron Polymaltose Complex [NP] | Injection 100 mg (iron) in 2 mL ampoule | Injection | 5 | .. | Ferrosig |
| Ferrum H | |||||
| Iron Sucrose [NP] | Concentrate for solution for infusion 2.7 g (equivalent to 100 mg iron (III)) in 5 mL ampoule | Injection | 5 | .. | Venofer |
| Isoleucine with carbohydrate [NP] | Sachets of oral powder 4 g containing 50 mg isoleucine, 30 (Isoleucine Amino Acid Supplement) | Oral | 4 | 5 | Isoleucine Amino Acid Supplement |
| Sachets of oral powder 4 g containing 1 g isoleucine, 30 (Isoleucine 1000 Amino Acid Supplement) | Oral | 4 | 5 | Isoleucine 1000 Amino Acid Supplement | |
| Isoniazid [NP] | Tablet 100 mg | Oral | 100 | 2 | Fawns and McAllan Proprietary Limited |
| Isosorbide Dinitrate [NP] | Tablet 10 mg | Oral | 200 | 2 | Sorbidin |
| Tablet 5 mg (sublingual) | Oral | 200 | 2 | Isordil Sublingual | |
| Isosorbide Mononitrate [NP] | Tablet 60 mg (sustained release) | Oral | 30 | 5 | Chem mart Isosorbide Mononitrate |
| Duride | |||||
| GenRx Isosorbide Mononitrate | |||||
| Imdur Durule | |||||
| Imtrate 60 mg | |||||
| Isomonit | |||||
| Monodur 60 mg | |||||
| Terry White Chemists Isosorbide Mononitrate | |||||
| Tablet 120 mg (sustained release) | Oral | 30 | 5 | Imdur 120 mg | |
| Monodur 120 mg | |||||
| Isotretinoin | Capsule 10 mg | Oral | 60 | 3 | Oratane |
| Roaccutane | |||||
| Capsule 20 mg | Oral | 60 | 3 | GenRx Isotretinoin | |
| Oratane | |||||
| Roaccutane | |||||
| Capsule 40 mg | Oral | 30 | 3 | Oratane | |
| Itraconazole [NP] | Capsule 100 mg | Oral | 60 | 5 | Sporanox |
| Ivermectin [NP] | Tablet 3 mg | Oral | 4 | .. | Stromectol |
| Ketoconazole [NP] | Tablet 200 mg | Oral | 10 | .. | Nizoral |
| Cream 20 mg per g, 30 g | Application | 1 | 2 | Nizoral 2% Cream | |
| Shampoo 10 mg per g, 100 mL | Application | 1 | 1 | Nizoral 1% | |
| Shampoo 20 mg per g, 60 mL | Application | 1 | 1 | Nizoral 2% | |
| Ketoprofen [NP] | Capsule 200 mg (sustained release) | Oral | 28 | 3 | Orudis SR 200 |
| Oruvail SR | |||||
| Suppository 100 mg | Rectal | 40 | 3 | Orudis | |
| Labetalol [NP] | Tablet containing labetalol hydrochloride 100 mg | Oral | 100 | 5 | Presolol 100 |
| Trandate | |||||
| Tablet containing labetalol hydrochloride 200 mg | Oral | 100 | 5 | Presolol 200 | |
| Trandate | |||||
| Lacosamide [NP] | Tablet 50 mg | Oral | 14 | 1 | Vimpat |
| Tablets 100 mg, 14 | Oral | 1 | 1 | Vimpat | |
| Tablet 100 mg | Oral | 56 | 5 | Vimpat | |
| Tablets 150 mg, 14 | Oral | 1 | 1 | Vimpat | |
| Tablet 150 mg | Oral | 56 | 5 | Vimpat | |
| Tablet 200 mg | Oral | 56 | 5 | Vimpat | |
| Lactulose [NP] | Solution BP 3.34 g per 5 mL, 500 mL | Oral | 1 | 5 | Actilax |
| Duphalac | |||||
| Genlac | |||||
| GenRx Lactulose | |||||
| Lac-Dol | |||||
| Lactocur | |||||
| Lamotrigine [NP] | Tablet 5 mg | Oral | 56 | 5 | Lamictal |
| Lamogine | |||||
| Seaze 5 | |||||
| Tablet 25 mg | Oral | 56 | 5 | APO-Lamotrigine | |
| GenRx Lamotrigine | |||||
| Lamictal | |||||
| Lamidus | |||||
| Lamogine | |||||
| Lamotrigine-DP | |||||
| Lamotrigine-GA | |||||
| Lamotrigine generichealth | |||||
| Lamotrigine Sandoz | |||||
| Lamotrust 25 | |||||
| Seaze 25 | |||||
| Tablet 50 mg | Oral | 56 | 5 | APO-Lamotrigine | |
| GenRx Lamotrigine | |||||
| Lamictal | |||||
| Lamidus | |||||
| Lamogine | |||||
| Lamotrigine-DP | |||||
| Lamotrigine-GA | |||||
| Lamotrigine generichealth | |||||
| Lamotrigine Sandoz | |||||
| Lamotrust 50 | |||||
| Seaze 50 | |||||
| Tablet 100 mg | Oral | 56 | 5 | APO-Lamotrigine | |
| GenRx Lamotrigine | |||||
| Lamictal | |||||
| Lamidus | |||||
| Lamogine | |||||
| Lamotrigine-DP | |||||
| Lamotrigine-GA | |||||
| Lamotrigine generichealth | |||||
| Lamotrigine Sandoz |
| SCHEDULE 3 - PART 1 | |||||
| Listed Drug | Form (strength, type, size, etc.) | Manner of adminis- tration | Maximum quantity | Maximum number of repeats | Brand |
| Adrenaline | Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000) | Injection | 5 | .. | AstraZeneca Pty Ltd |
| Amoxycillin | Capsule 250 mg (as trihydrate) | Oral | 20 | .. | Alphamox 250 |
| Amoxil | |||||
| Amoxycillin-GA | |||||
| Amoxycillin Ranbaxy | |||||
| Amoxycillin Sandoz | |||||
| APO-Amoxycillin | |||||
| Chem mart Amoxycillin | |||||
| Cilamox | |||||
| GenRx Amoxycillin | |||||
| Terry White Chemists Amoxycillin | |||||
| Capsule 500 mg (as trihydrate) | Oral | 20 | .. | Alphamox 500 | |
| Amoxil | |||||
| Amoxycillin-GA | |||||
| Amoxycillin Ranbaxy | |||||
| Amoxycillin Sandoz | |||||
| APO-Amoxycillin | |||||
| Chem mart Amoxycillin | |||||
| Cilamox | |||||
| GenRx Amoxycillin | |||||
| Terry White Chemists Amoxycillin | |||||
| Sachet containing oral powder 3 g (as trihydrate) | Oral | 1 | .. | Amoxil | |
| Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL | Oral | 1 | .. | Amoxil | |
| Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL | Oral | 1 | .. | Alphamox 125 | |
| Amoxil | |||||
| Amoxycillin Sandoz | |||||
| Bgramin | |||||
| Chem mart Amoxycillin | |||||
| GenRx Amoxycillin | |||||
| Ranmoxy | |||||
| Terry White Chemists Amoxycillin | |||||
| Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL | Oral | 1 | .. | Alphamox 250 | |
| Amoxil Forte | |||||
| Amoxycillin Sandoz | |||||
| Bgramin | |||||
| Chem mart Amoxycillin | |||||
| Cilamox | |||||
| GenRx Amoxycillin | |||||
| Ranmoxy | |||||
| Terry White Chemists Amoxycillin | |||||
| Powder for oral suspension 500 mg (as trihydrate) per 5 mL, 100 mL | Oral | 1 | .. | Maxamox | |
| Amoxycillin with Clavulanic Acid | Tablet containing 500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) | Oral | 10 | .. | Amoxycillin/Clavulanic Acid 500/125 generichealth |
| APO-Amoxycillin/ Clavulanic Acid 500/125 | |||||
| Augmentin Duo | |||||
| Clamoxyl Duo | |||||
| Curam Duo 500/125 | |||||
| GA-Amclav 500/125 | |||||
| Moxiclav Duo 500/125 | |||||
| Tablet containing 875 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) | Oral | 10 | .. | Amoxycillin/Clavulanic Acid 875/125 generichealth | |
| Augmentin Duo forte | |||||
| Chem mart Amoxycillin and Clavulanic Acid | |||||
| Clamoxyl Duo forte | |||||
| Clavycillin 875/125 | |||||
| Curam Duo Forte 875/125 | |||||
| GA-Amclav Forte 875/125 | |||||
| GenRx Amoxycillin and Clavulanic Acid | |||||
| Moxiclav Duo Forte 875/125 | |||||
| Terry White Chemists Amoxycillin and Clavulanic Acid | |||||
| Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL | Oral | 1 | .. | Augmentin | |
| Clamoxyl | |||||
| Curam | |||||
| Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL | Oral | 1 | .. | Augmentin Duo 400 | |
| Clamoxyl Duo 400 | |||||
| Curam Duo | |||||
| Amphotericin | Lozenge 10 mg | Oral | 20 | .. | Fungilin |
| Ampicillin | Powder for injection 500 mg (as sodium) | Injection | 5 | .. | Austrapen |
| Ibimicyn | |||||
| Powder for injection 1 g (as sodium) | Injection | 5 | .. | Aspen Ampicyn | |
| Austrapen | |||||
| Ibimicyn | |||||
| Aspirin | Tablet, dispersible, 300 mg | Oral | 96 | .. | Solprin |
| Atropine | Injection containing atropine sulfate 600 micrograms in 1 mL | Injection | 10 | .. | AstraZeneca Pty Ltd |
| Benzathine benzylpenicillin | Injection 900 mg in 2.3 mL single use pre-filled syringe | Injection | 10 | .. | Bicillin L-A |
| Benztropine | Injection containing benztropine mesylate 2 mg in 2 mL | Injection | 5 | .. | Cogentin |
| Benzydamine | Mouth and throat rinse containing benzydamine hydrochloride 22.5 mg per 15 mL, 500 mL | Oral application | 1 | .. | Difflam |
| Benzylpenicillin | Powder for injection 600 mg (as sodium) | Injection | 10 | .. | BenPen |
| Powder for injection 3 g (as sodium) | Injection | 10 | .. | BenPen | |
| Betamethasone | Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL | Injection | 5 | .. | Celestone Chronodose |
| Carbamazepine | Tablet 100 mg | Oral | 200 | .. | Carbamazepine Sandoz |
| Tegretol 100 | |||||
| Tablet 200 mg | Oral | 200 | .. | Carbamazepine Sandoz | |
| Tegretol 200 | |||||
| Teril | |||||
| Tablet 200 mg (controlled release) | Oral | 200 | .. | Tegretol CR 200 | |
| Tablet 400 mg (controlled release) | Oral | 200 | .. | Tegretol CR 400 | |
| Oral suspension 100 mg per 5 mL, 300 mL | Oral | 1 | .. | Tegretol Liquid | |
| Cefaclor | Tablet (sustained release) 375 mg (as monohydrate) | Oral | 10 | .. | Ceclor CD |
| Cefaclor-GA | |||||
| Chem mart Cefaclor CD | |||||
| Douglas Cefaclor-CD | |||||
| GenRx Cefaclor CD | |||||
| Karlor CD | |||||
| Keflor CD | |||||
| Ozcef | |||||
| Terry White Chemists Cefaclor CD | |||||
| Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL | Oral | 1 | .. | Aclor 125 | |
| Ceclor | |||||
| Cefaclor Sandoz | |||||
| Chem mart Cefaclor | |||||
| GenRx Cefaclor | |||||
| Keflor | |||||
| Ozcef | |||||
| Terry White Chemists Cefaclor | |||||
| Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL | Oral | 1 | .. | Aclor 250 | |
| Ceclor | |||||
| Cefaclor Sandoz | |||||
| Chem mart Cefaclor | |||||
| GenRx Cefaclor | |||||
| Keflor | |||||
| Ozcef | |||||
| Terry White Chemists Cefaclor | |||||
| Cefalotin | Powder for injection 1 g (as sodium) | Injection | 10 | .. | Cefalotin Sandoz |
| Hospira Pty Limited | |||||
| Keflin Neutral | |||||
| Cefotaxime | Powder for injection 1 g (as sodium) | Injection | 10 | .. | Cefotaxime Sandoz |
| Hospira Pty Limited | |||||
| Powder for injection 2 g (as sodium) | Injection | 10 | .. | Cefotaxime Sandoz | |
| Hospira Pty Limited | |||||
| Cefuroxime | Tablet 250 mg (as axetil) | Oral | 14 | .. | Zinnat |
| Cephalexin | Capsule 250 mg (anhydrous) | Oral | 20 | .. | Cefalexin Sandoz |
| Cephabell | |||||
| Cephalexin generichealth | |||||
| Cephatrust 250 | |||||
| Chem mart Cephalexin | |||||
| Cilex | |||||
| GenRx Cephalexin | |||||
| Ialex | |||||
| Ibilex 250 | |||||
| Keflex | |||||
| Rancef | |||||
| Terry White Chemists Cephalexin | |||||
| Capsule 500 mg (anhydrous) | Oral | 20 | .. | Cefalexin Sandoz | |
| Cephabell | |||||
| Cephalexin generichealth | |||||
| Cephatrust 500 | |||||
| Chem mart Cephalexin | |||||
| Cilex | |||||
| GenRx Cephalexin | |||||
| Ialex | |||||
| Ibilex 500 | |||||
| Keflex | |||||
| Rancef | |||||
| Terry White Chemists Cephalexin | |||||
| Granules for oral suspension 125 mg per 5 mL, 100 mL | Oral | 1 | .. | APO-Cephalexin | |
| Cefalexin Sandoz | |||||
| Chem mart Cephalexin | |||||
| Cilex | |||||
| GenRx Cephalexin | |||||
| Ialex | |||||
| Ibilex 125 | |||||
| Keflex | |||||
| Terry White Chemists Cephalexin | |||||
| Granules for oral suspension 250 mg per 5 mL, 100 mL | Oral | 1 | .. | APO-Cephalexin | |
| Cefalexin Sandoz | |||||
| Chem mart Cephalexin | |||||
| Cilex | |||||
| GenRx Cephalexin | |||||
| Ialex | |||||
| Ibilex 250 | |||||
| Keflex | |||||
| Terry White Chemists Cephalexin | |||||
| Chloramphenicol | Eye drops 5 mg per mL, 10 mL | Application to the eye | 1 | .. | Chloromycetin |
| Chlorsig | |||||
| Clindamycin | Capsule 150 mg (as hydrochloride) | Oral | 24 | .. | Cleocin |
| Dalacin C | |||||
| Codeine | Tablet containing codeine phosphate 30 mg | Oral | 20 | .. | Fawns and McAllan Proprietary Limited |
| Codeine with Paracetamol | Tablet containing codeine phosphate 30 mg with paracetamol 500 mg | Oral | 20 | .. | APO- Paracetamol/Codeine 500/30 |
| Codalgin Forte | |||||
| Codapane Forte | |||||
| Comfarol Forte | |||||
| Dolaforte | |||||
| Panadeine Forte | |||||
| Prodeine Forte | |||||
| Diazepam | Tablet 2 mg | Oral | 50 | .. | Antenex 2 |
| Valium | |||||
| Valpam 2 | |||||
| Tablet 5 mg | Oral | 50 | .. | Antenex 5 | |
| Diazepam-GA | |||||
| Ranzepam | |||||
| Valium | |||||
| Valpam 5 | |||||
| Injection 10 mg in 2 mL | Injection | 5 | .. | Hospira Pty Limited | |
| Diclofenac | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | 100 | .. | APO-Diclofenac |
| Chem mart Diclofenac | |||||
| Clonac 25 | |||||
| Diclofenac-GA | |||||
| Diclofenac Sandoz | |||||
| Fenac 25 | |||||
| Terry White Chemists Diclofenac | |||||
| Voltaren 25 | |||||
| Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | 50 | .. | APO-Diclofenac | |
| Chem mart Diclofenac | |||||
| Clonac 50 | |||||
| Diclofenac-GA | |||||
| Diclofenac Sandoz | |||||
| Fenac | |||||
| Terry White Chemists Diclofenac | |||||
| Voltaren 50 | |||||
| Suppository containing diclofenac sodium 100 mg | Rectal | 40 | .. | Voltaren 100 | |
| Dicloxacillin | Capsule 250 mg (as sodium) | Oral | 24 | .. | Dicloxsig |
| Distaph 250 | |||||
| Capsule 500 mg (as sodium) | Oral | 24 | .. | Diclocil | |
| Dicloxsig | |||||
| Distaph 500 | |||||
| Doxycycline | Tablet 100 mg (as monohydrate) | Oral | 7 | .. | Chem mart Doxycycline |
| Doxyhexal | |||||
| GenRx Doxycycline | |||||
| Terry White Chemists Doxycycline | |||||
| Tablet 100 mg (as hydrochloride) | Oral | 7 | .. | Doxsig | |
| Doxy-100 | |||||
| Doxylin 100 | |||||
| Vibramycin | |||||
| Capsule 100 mg (as hydrochloride) (containing enteric coated pellets) | Oral | 7 | .. | Doryx | |
| Mayne Pharma Doxycycline | |||||
| Erythromycin | Tablet 400 mg (as ethyl succinate) | Oral | 25 | .. | E.E.S. 400 Filmtab |
| E-Mycin | |||||
| Capsule 250 mg (containing enteric coated pellets) | Oral | 25 | .. | Eryc | |
| Mayne Pharma Erythromycin | |||||
| Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | 1 | .. | E.E.S. 200 | |
| E-Mycin 200 | |||||
| Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | 1 | .. | E.E.S. Granules | |
| E-Mycin 400 | |||||
| Powder for I.V. infusion 1 g (as lactobionate) | Injection | 5 | .. | Erythrocin-I.V. | |
| Flucloxacillin | Capsule 250 mg (as sodium) | Oral | 24 | .. | Flopen |
| Staphylex 250 | |||||
| Capsule 500 mg (as sodium) | Oral | 24 | .. | Flopen | |
| Staphylex 500 | |||||
| Powder for oral liquid 125 mg (as sodium) per 5 mL, 100 mL | Oral | 1 | .. | Aspen Pharmacare Australia Pty Limited | |
| Powder for oral liquid 250 mg (as sodium) per 5 mL, 100 mL | Oral | 1 | .. | Aspen Pharmacare Australia Pty Limited | |
| Powder for injection 500 mg (as sodium) | Injection | 5 | .. | Flubiclox | |
| Flucil | |||||
| Powder for injection 1 g (as sodium) | Injection | 5 | .. | Flubiclox | |
| Flucil | |||||
| Hospira Pty Limited | |||||
| Glucagon | Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe | Injection | 1 | .. | GlucaGen Hypokit |
| Glucose | I.V. infusion 139 mmol (anhydrous) per 500 mL, 500 mL | Injection | 5 | .. | B. Braun Australia Pty Ltd |
| Fresenius Kabi Australia Pty Limited | |||||
| I.V. infusion 278 mmol (anhydrous) per L, 1 L | Injection | 5 | .. | B. Braun Australia Pty Ltd | |
| Baxter Healthcare Pty Ltd | |||||
| Fresenius Kabi Australia Pty Limited | |||||
| Glyceryl Trinitrate | Tablets 600 micrograms, 100 | Buccal/sublingual | 1 | .. | Anginine Stabilised |
| Lycinate | |||||
| Hydrocortisone | Injection 100 mg (as sodium succinate) with 2 mL solvent | Injection | 6 | .. | Solu-Cortef |
| Injection 250 mg (as sodium succinate) with 2 mL solvent | Injection | 6 | .. | Solu-Cortef | |
| Cream containing hydrocortisone acetate 10 mg per g, 30 g | Application | 1 | .. | Cortic-DS 1% | |
| Sigmacort | |||||
| Cream containing hydrocortisone acetate 10 mg per g, 50 g | Application | 1 | .. | Cortef | |
| Cortic-DS 1% | |||||
| Sigmacort | |||||
| Ointment containing hydrocortisone acetate 10 mg per g, 30 g | Application | 1 | .. | Cortic-DS 1% | |
| Sigmacort | |||||
| Ointment containing hydrocortisone acetate 10 mg per g, 50 g | Application | 1 | .. | Cortic-DS 1% | |
| Sigmacort | |||||
| Hydromorphone | Tablet containing hydromorphone hydrochloride 2 mg | Oral | 20 | .. | Dilaudid |
| Tablet containing hydromorphone hydrochloride 4 mg | Oral | 20 | .. | Dilaudid | |
| Tablet containing hydromorphone hydrochloride 8 mg | Oral | 20 | .. | Dilaudid | |
| Tablet (modified release) containing hydromorphone hydrochloride 4 mg | Oral | 14 | .. | Jurnista | |
| Tablet (modified release) containing hydromorphone hydrochloride 8 mg | Oral | 14 | .. | Jurnista | |
| Tablet (modified release) containing hydromorphone hydrochloride 16 mg | Oral | 14 | .. | Jurnista | |
| Tablet (modified release) containing hydromorphone hydrochloride 32 mg | Oral | 14 | .. | Jurnista | |
| Tablet (modified release) containing hydromorphone hydrochloride 64 mg | Oral | 14 | .. | Jurnista | |
| Oral liquid containing hydromorphone hydrochloride 1 mg per mL, 473 mL | Oral | 1 | .. | Dilaudid | |
| Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | 5 | .. | Dilaudid | |
| Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | 5 | .. | Dilaudid-HP | |
| Injection containing hydromorphone hydrochloride 50 mg in 5 mL | Injection | 5 | .. | Dilaudid-HP | |
| Ibuprofen | Tablet 400 mg | Oral | 30 | .. | Brufen |
| Indomethacin | Capsule 25 mg | Oral | 100 | .. | Arthrexin |
| Indocid | |||||
| Suppository 100 mg | Rectal | 40 | .. | Indocid | |
| Ketoprofen | Capsule 200 mg (sustained release) | Oral | 28 | .. | Orudis SR 200 |
| Oruvail SR | |||||
| Suppository 100 mg | Rectal | 40 | .. | Orudis | |
| Lignocaine | Injection containing lignocaine hydrochloride 100 mg in 5 mL | Injection | 5 | .. | Pfizer Australia Pty Ltd |
| Lincomycin | Injection 600 mg (as hydrochloride) in 2 mL | Injection | 5 | .. | Lincocin |
| Methylprednisolone | Injection containing methylprednisolone acetate 40 mg in 1 mL | Injection | 5 | .. | Depo-Medrol |
| Depo-Nisolone | |||||
| Metoclopramide | Tablet containing metoclopramide hydrochloride 10 mg | Oral | 25 | .. | Maxolon |
| Pramin | |||||
| Injection containing metoclopramide hydrochloride 10 mg in 2 mL | Injection | 10 | .. | Maxolon | |
| Metronidazole | Tablet 200 mg | Oral | 21 | .. | Flagyl |
| Metrogyl 200 | |||||
| Metronide 200 | |||||
| Tablet 400 mg | Oral | 5 | .. | Metrogyl 400 | |
| Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL | Oral | 1 | .. | Flagyl S | |
| I.V. infusion 500 mg in 100 mL | Injection | 5 | .. | Baxter Healthcare Pty Ltd | |
| DBL Metronidazole Intravenous Infusion | |||||
| Metronidazole Sandoz | |||||
| Suppositories 500 mg, 10 | Rectal | 1 | .. | Flagyl | |
| Morphine | Tablet containing morphine sulfate 30 mg | Oral | 20 | .. | Anamorph |
| Tablet containing morphine sulfate 5 mg (controlled release) | Oral | 20 | .. | MS Contin | |
| Tablet containing morphine sulfate 10 mg (controlled release) | Oral | 20 | .. | Momex SR 10 | |
| MS Contin | |||||
| Tablet containing morphine sulfate 15 mg (controlled release) | Oral | 20 | .. | MS Contin | |
| Tablet containing morphine sulfate 30 mg (controlled release) | Oral | 20 | .. | Momex SR 30 | |
| MS Contin | |||||
| Tablet containing morphine sulfate 60 mg (controlled release) | Oral | 20 | .. | Momex SR 60 | |
| MS Contin | |||||
| Tablet containing morphine sulfate 100 mg (controlled release) | Oral | 20 | .. | Momex SR 100 | |
| MS Contin | |||||
| Capsule containing morphine sulfate 10 mg (containing sustained release pellets) | Oral | 20 | .. | Kapanol | |
| Capsule containing morphine sulfate 20 mg (containing sustained release pellets) | Oral | 20 | .. | Kapanol | |
| Capsule containing morphine sulfate 30 mg (controlled release) | Oral | 10 | .. | MS Mono | |
| Capsule containing morphine sulfate 50 mg (containing sustained release pellets) | Oral | 20 | .. | Kapanol | |
| Capsule containing morphine sulfate 60 mg (controlled release) | Oral | 10 | .. | MS Mono | |
| Capsule containing morphine sulfate 90 mg (controlled release) | Oral | 10 | .. | MS Mono | |
| Capsule containing morphine sulfate 100 mg (containing sustained release pellets) | Oral | 20 | .. | Kapanol | |
| Capsule containing morphine sulfate 120 mg (controlled release) | Oral | 10 | .. | MS Mono | |
| Sachet containing controlled release granules for oral suspension, containing morphine sulfate 20 mg per sachet | Oral | 20 | .. | MS Contin Suspension 20 mg | |
| Sachet containing controlled release granules for oral suspension, containing morphine sulfate 30 mg per sachet | Oral | 20 | .. | MS Contin Suspension 30 mg | |
| Sachet containing controlled release granules for oral suspension, containing morphine sulfate 60 mg per sachet | Oral | 20 | .. | MS Contin Suspension 60 mg | |
| Sachet containing controlled release granules for oral suspension, containing morphine sulfate 100 mg per sachet | Oral | 20 | .. | MS Contin Suspension 100 mg | |
| Oral solution containing morphine hydrochloride 2 mg per mL, 200 mL | Oral | 1 | .. | Ordine 2 | |
| Oral solution containing morphine hydrochloride 5 mg per mL, 200 mL | Oral | 1 | .. | Ordine 5 | |
| Oral solution containing morphine hydrochloride 10 mg per mL, 200 mL | Oral | 1 | .. | Ordine 10 | |
| Injection containing morphine sulfate 10 mg in 1 mL | Injection | 5 | .. | Hospira Pty Limited | |
| Injection containing morphine sulfate 15 mg in 1 mL | Injection | 5 | .. | Hospira Pty Limited | |
| Injection containing morphine sulfate 30 mg in 1 mL | Injection | 5 | .. | Hospira Pty Limited | |
| Naloxone | Injection containing naloxone hydrochloride 2 mg in 5 mL disposable injection set | Injection | 1 | .. | Naloxone Min-I-Jet |
| Naproxen | Tablet 250 mg | Oral | 100 | .. | Inza 250 |
| Naprosyn | |||||
| Tablet containing naproxen sodium 550 mg | Oral | 50 | .. | Anaprox 550 | |
| Crysanal | |||||
| Tablet 500 mg | Oral | 50 | .. | Inza 500 | |
| Naprosyn | |||||
| Tablet 750 mg (sustained release) | Oral | 28 | .. | Naprosyn SR750 | |
| Proxen SR 750 | |||||
| Tablet 1 g (sustained release) | Oral | 28 | .. | Naprosyn SR1000 | |
| Proxen SR 1000 | |||||
| Nitrazepam | Tablet 5 mg | Oral | 25 | .. | Alodorm |
| Mogadon | |||||
| Nystatin | Tablet 500,000 units | Oral | 50 | .. | Nilstat |
| Capsule 500,000 units | Oral | 50 | .. | Nilstat | |
| Oral suspension 100,000 units per mL, 24 mL | Oral | 1 | .. | Mycostatin | |
| Nilstat | |||||
| Oxazepam | Tablet 15 mg | Oral | 25 | .. | Alepam 15 |
| Serepax | |||||
| Tablet 30 mg | Oral | 25 | .. | Alepam 30 | |
| APO-Oxazepam | |||||
| Murelax | |||||
| Serepax | |||||
| Oxycodone | Tablet containing oxycodone hydrochloride 5 mg | Oral | 20 | .. | Endone |
| Capsule containing oxycodone hydrochloride 5 mg | Oral | 20 | .. | OxyNorm | |
| Capsule containing oxycodone hydrochloride 10 mg | Oral | 20 | .. | OxyNorm | |
| Capsule containing oxycodone hydrochloride 20 mg | Oral | 20 | .. | OxyNorm | |
| Oral solution containing oxycodone hydrochloride 5 mg per 5 mL, 250 mL | Oral | 1 | .. | OxyNorm Liquid 5mg/5mL | |
| Tablet containing oxycodone hydrochloride 5 mg (controlled release) | Oral | 20 | .. | OxyContin | |
| Tablet containing oxycodone hydrochloride 10 mg (controlled release) | Oral | 20 | .. | OxyContin | |
| Tablet containing oxycodone hydrochloride 15 mg (controlled release) | Oral | 20 | .. | OxyContin | |
| Tablet containing oxycodone hydrochloride 20 mg (controlled release) | Oral | 20 | .. | OxyContin | |
| Tablet containing oxycodone hydrochloride 30 mg (controlled release) | Oral | 20 | .. | OxyContin | |
| Tablet containing oxycodone hydrochloride 40 mg (controlled release) | Oral | 20 | .. | OxyContin | |
| Tablet containing oxycodone hydrochloride 80 mg (controlled release) | Oral | 20 | .. | OxyContin | |
| Suppository 30 mg (as pectinate) | Rectal | 12 | .. | Proladone | |
| Paracetamol | Tablet 500 mg | Oral | 100 | .. | APO-Paracetamol |
| Chem mart Paracetamol | |||||
| Febridol | |||||
| Generic Health Pty Ltd | |||||
| Panamax | |||||
| Paracetamol Sandoz | |||||
| Paralgin | |||||
| Pharmacy Choice Paracetamol | |||||
| Terry White Chemists Paracetamol | |||||
| Oral liquid 120 mg per 5 mL, 100 mL | Oral | 1 | .. | Panamax | |
| Oral liquid 240 mg per 5 mL, 200 mL | Oral | 1 | .. | Panamax 240 Elixir | |
| Phenoxymethylpenicillin | Tablet 250 mg phenoxymethylpenicillin (as potassium) | Oral | 50 | .. | Abbocillin-VK Filmtab |
| Tablet 500 mg phenoxymethylpenicillin (as potassium) | Oral | 50 | .. | Abbocillin-VK Filmtab | |
| Capsule 250 mg phenoxymethylpenicillin (as potassium) | Oral | 50 | .. | Cilicaine VK | |
| Cilopen VK | |||||
| LPV | |||||
| Capsule 500 mg phenoxymethylpenicillin (as potassium) | Oral | 50 | .. | Cilicaine VK | |
| Cilopen VK | |||||
| LPV | |||||
| Oral suspension 150 mg (as benzathine) per 5 mL, 100 mL | Oral | 2 | .. | Abbocillin-V | |
| Cilicaine V | |||||
| Piroxicam | Dispersible tablet 10 mg | Oral | 50 | .. | Mobilis D-10 |
| Dispersible tablet 20 mg | Oral | 25 | .. | Feldene-D | |
| Mobilis D-20 | |||||
| Capsule 10 mg | Oral | 50 | .. | Chem mart Piroxicam | |
| Feldene | |||||
| GenRx Piroxicam | |||||
| Mobilis 10 | |||||
| Terry White Chemists Piroxicam | |||||
| Capsule 20 mg | Oral | 25 | .. | Chem mart Piroxicam | |
| Feldene | |||||
| GenRx Piroxicam | |||||
| Mobilis 20 | |||||
| Terry White Chemists Piroxicam | |||||
| Procaine Penicillin | Injection 1.5 g in disposable syringe | Injection | 5 | .. | Cilicaine |
| Prochlorperazine | Tablet containing prochlorperazine maleate 5 mg | Oral | 25 | .. | Prochlorperazine-GA |
| Stemetil | |||||
| Stemzine | |||||
| Injection containing prochlorperazine mesylate 12.5 mg in 1 mL | Injection | 10 | .. | Stemetil | |
| Suppositories containing prochlorperazine equivalent to 25 mg prochlorperazine maleate, 5 | Rectal | 1 | .. | Stemetil | |
| Promethazine | Injection containing promethazine hydrochloride 50 mg in 2 mL | Injection | 10 | .. | Hospira Pty Limited |
| Roxithromycin | Tablet for oral suspension 50 mg | Oral | 10 | .. | Rulide D |
| Tablet 150 mg | Oral | 10 | .. | APO-Roxithromycin | |
| Biaxsig | |||||
| Chem mart Roxithromycin | |||||
| Roxar 150 | |||||
| Roxide | |||||
| Roximycin | |||||
| Roxithromycin-GA | |||||
| Rulide | |||||
| Terry White Chemists Roxithromycin | |||||
| Tablet 300 mg | Oral | 5 | .. | APO-Roxithromycin | |
| Biaxsig | |||||
| Chem mart Roxithromycin | |||||
| Roxar 300 | |||||
| Roxide | |||||
| Roximycin | |||||
| Roxithromycin-GA | |||||
| Rulide | |||||
| Terry White Chemists Roxithromycin | |||||
| Sodium Chloride | Injection 9 mg per mL, 10 mL | Injection/solvent for injectables | 5 | .. | Pfizer Australia Pty Ltd |
| I.V. infusion 77 mmol per 500 mL, 500 mL | Injection | 5 | .. | B. Braun Australia Pty Ltd | |
| Fresenius Kabi Australia Pty Limited | |||||
| I.V. infusion 154 mmol per L, 1 L | Injection | 5 | .. | B. Braun Australia Pty Ltd | |
| Baxter Healthcare Pty Ltd | |||||
| Fresenius Kabi Australia Pty Limited | |||||
| I.V. infusion 513 mmol per L, 1 L | Injection | 2 | .. | Baxter Healthcare Pty Ltd | |
| Sodium Chloride with Glucose | I.V. infusion 31 mmol-222 mmol (anhydrous) per L, 1 L | Injection | 5 | .. | Baxter Healthcare Pty Ltd |
| I.V. infusion 19 mmol-104 mmol (anhydrous) per 500 mL, 500 mL | Injection | 5 | .. | Baxter Healthcare Pty Ltd | |
| I.V. infusion 39 mmol-69 mmol (anhydrous) per 500 mL, 500 mL | Injection | 5 | .. | Baxter Healthcare Pty Ltd | |
| Sulindac | Tablet 100 mg | Oral | 100 | .. | Aclin |
| Tablet 200 mg | Oral | 50 | .. | Aclin 200 | |
| Temazepam | Tablet 10 mg | Oral | 25 | .. | APO-Temazepam |
| Normison | |||||
| Temaze | |||||
| Temtabs | |||||
| Ticarcillin with Clavulanic Acid | Powder for injection containing ticarcillin 3 g (as sodium) with 100 mg clavulanic acid (as potassium clavulanate) (with any determined brand of sodium chloride injection as the required solvent) | Injection | 10 | .. | Timentin |
| Tramadol | Capsule containing tramadol hydrochloride 50 mg | Oral | 20 | .. | Chem mart Tramadol |
| GA Tramadol 50mg | |||||
| GenRx Tramadol | |||||
| Lodam 50 | |||||
| Terry White Chemists Tramadol | |||||
| Tramadol Sandoz | |||||
| Tramal | |||||
| Tramedo | |||||
| Zydol | |||||
| Tablet (sustained release) containing tramadol hydrochloride 50 mg | Oral | 20 | .. | Tramal SR 50 | |
| Tablet (sustained release) containing tramadol hydrochloride 100 mg | Oral | 20 | .. | APO-Tramadol SR | |
| Chem mart Tramadol SR | |||||
| GA Tramadol SR 100mg | |||||
| Lodam SR 100 | |||||
| Terry White Chemists Tramadol SR | |||||
| Tramahexal SR | |||||
| Tramal SR 100 | |||||
| Tramedo SR 100 | |||||
| Zydol SR 100 | |||||
| Tablet (extended release) containing tramadol hydrochloride 100 mg | Oral | 10 | .. | Durotram XR | |
| Tablet (sustained release) containing tramadol hydrochloride 150 mg | Oral | 20 | .. | APO-Tramadol SR | |
| Chem mart Tramadol SR | |||||
| GA Tramadol SR 150mg | |||||
| Lodam SR 150 | |||||
| Terry White Chemists Tramadol SR | |||||
| Tramahexal SR | |||||
| Tramal SR 150 | |||||
| Tramedo SR 150 | |||||
| Zydol SR 150 | |||||
| Tablet (sustained release) containing tramadol hydrochloride 200 mg | Oral | 20 | .. | APO-Tramadol SR | |
| Chem mart Tramadol SR | |||||
| GA Tramadol SR 200mg | |||||
| Lodam SR 200 | |||||
| Terry White Chemists Tramadol SR | |||||
| Tramahexal SR | |||||
| Tramal SR 200 | |||||
| Tramedo SR 200 | |||||
| Zydol SR 200 | |||||
| Tablet (extended release) containing tramadol hydrochloride 200 mg | Oral | 10 | .. | Durotram XR | |
| Tablet (extended release) containing tramadol hydrochloride 300 mg | Oral | 10 | .. | Durotram XR | |
| Oral drops containing tramadol hydrochloride 100 mg per mL, 10 mL | Oral | 1 | .. | Tramal | |
| Injection containing tramadol hydrochloride 100 mg in 2 mL | Injection | 5 | .. | Tramahexal | |
| Tramal 100 | |||||
| Triamcinolone | Injection containing triamcinolone acetonide 10 mg in 1 mL | Injection | 5 | .. | Kenacort-A10 |
| Trimethoprim with Sulfamethoxazole | Tablet 80 mg-400 mg | Oral | 10 | .. | Resprim |
| Tablet 160 mg-800 mg | Oral | 10 | .. | Bactrim DS | |
| Resprim Forte | |||||
| Septrin Forte | |||||
| Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL | Oral | 1 | .. | Bactrim | |
| Septrin | |||||
| Vancomycin | Powder for injection 500 mg (500,000 I.U.) (as hydrochloride) | Injection | 2 | .. | Hospira Pty Limited |
| Vancocin CP | |||||
| Vancomycin Sandoz | |||||
| Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride) | Injection | 1 | .. | Hospira Pty Limited | |
| Vancomycin Sandoz | |||||
| SCHEDULE 3 - PART 2 | ||||||
| Listed Drug | Form (strength, type, size, etc.) | Purposes | Manner of adminis- tration | Maximum quantity | Maximum number of repeats | Brand |
| Ibuprofen | Tablet 400 mg | Chronic arthropathies (including osteoarthritis) with an inflammatory component Bone pain due to malignant disease | Oral | 90 | .. | Brufen |
| Metronidazole | Tablet 400 mg | Treatment of anaerobic infections | Oral | 21 | .. | Flagyl Metrogyl 400 Metronide 400 |
| Paracetamol | Tablet 500 mg | Chronic arthropathies | Oral | 300 | .. | APO-Paracetamol Chem mart Paracetamol Febridol Generic Health Pty Ltd Panamax Paracetamol Sandoz Paralgin Pharmacy Choice Paracetamol Terry White Chemists Paracetamol |
| SCHEDULE 4 | ||
| Form of Medicinal Preparation | Maximum quantity | Maximum number of repeats |
| Creams | 100 g | 1 |
| Dusting Powders | 100 g | 1 |
| Ear Drops | 15 mL | 2 |
| Eye Drops containing Cocaine Hydrochloride BP | 15 mL | .. |
| Eye Drops, Other | 15 mL | 5 |
| Eye Lotions | 200 mL | 2 |
| Inhalations | 50 mL | 1 |
| Linctuses containing Codeine Phosphate BP | 100 mL | .. |
| Linctuses, Other | 100 mL | 2 |
| Lotions | 200 mL | 2 |
| Mixtures containing Codeine Phosphate BP | 200 mL | .. |
| Mixtures, Other | 200 mL | 4 |
| Mixtures for Children containing Codeine Phosphate BP | 100 mL | .. |
| Mixtures for Children, Other | 100 mL | 4 |
| Mouth Washes | 200 mL | 1 |
| Nasal Instillations | 15 mL | 2 |
| Ointments, Waxes | 100 g | 1 |
| Paints | 25 mL | 1 |
| Pastes containing Cocaine Hydrochloride BP | 25 g | .. |
| Pastes, Other | 100 g | 1 |
| Powders for Internal Use | 100 g | 2 |
| Solutions | 200 mL | 2 |
Notes to the Determination — Pharmaceutical benefits (PB 68 of 2010)
Note 1
The Determination — Pharmaceutical benefits (PB 68 of 2010) (in force under sections 85, 85A and 88 of the National Health Act 1953) as shown in this compilation is amended as indicated in the Tables below.
Table of Instruments
| Title | Date of FRLI Registration | Date of | Application, saving or |
| PB 68 of 2010 | 21 July 2010 (see F2010L02062) | 1 Aug 2010 | |
| PB 81 of 2010 | 6 Aug 2010 (see F2010L02247) | 1 Sept 2010 | — |
| PB 88 of 2010 | 23 Sept 2010 (see F2010L02527) | 1 Oct 2010 | — |
| PB 96 of 2010 | 29 Oct 2010 (see F2010L02855) | 1 Nov 2010 | — |
Table of Amendments
| ad. = added or inserted am. = amended rep. = repealed rs. = repealed and substituted | |||
| Provision affected | How affected | ||
| S. 3................................................... | am. PB 96 of 2010 | ||
| S. 5C................................................ | ad. PB 96 of 2010 | ||
| S. 5D................................................ | ad. PB 96 of 2010 | ||
| S. 7A................................................. | ad. PB 96 of 2010 | ||
| S. 8................................................... | am. PB 96 of 2010 | ||
| S. 10A............................................... | ad. PB 96 of 2010 | ||
| S. 10B.............................................. | ad. PB 96 of 2010 | ||
| S. 11................................................. | am. PB 96 of 2010 | ||
| S. 11A............................................... | am. PB 96 of 2010 | ||
| S. 12................................................. | am. PB 96 of 2010 | ||
| S. 12A............................................... | am. PB 96 of 2010 | ||
| S. 12B.............................................. | am. PB 96 of 2010 | ||
| S. 12BA............................................ | am. PB 96 of 2010 | ||
| Schedule 1 | |||
| Part 1................................................ | am. PB 81, 88 and 96 of 2010 | ||
| Part 2................................................ | am. PB 81, 88 and 96 of 2010 | ||
| Schedule 2 | |||
| Part 1................................................ | am. PB 96 of 2010 | ||
| Part 2................................................ | am. PB 96 of 2010 | ||
| Schedule 3 | |||
| Part 1................................................ | am. PB 81, 88 and 96 of 2010 | ||
0
0
0